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The use and applications of DNA and RNA analysis has become an invaluable forensic 
tool in criminal investigations. Recent research from this laboratory applied quantitative 
analysis of RNA as a means of estimating the age of crime scene samples. Linking the 
age of an evidentiary sample to the time a crime was committed can strengthen the 
prosecution of a perpetrator.  
Organisms exhibit a circadian rhythm that is observed as 24-hour cyclic processes that 
can be detected through oscillating quantities of mRNA and protein. It has been estimated 
that ten percent of the human transcriptome demonstrates rhythmic expression patterns of 
mRNA. Thus, an opportunity exists to harness a natural biologic process through 
quantitative RNA analysis to perhaps refine our ability to estimate when a crime scene 
sample was created.  
The aim of this current study was to determine if it is feasible to identify when, during a 
24-hour day, a blood stain was created at a crime scene. In order to establish a reference 
pattern of gene expression that reflects a 24-hour day, it was necessary to assess the 
stability of the mRNA transcripts from cycling genes in dried stains as well as to explore 
the variability in the expression of these genes among members of the population. Results 
demonstrated that all transcripts studied were stable for the short period between 
production of a blood stain and the extraction and reverse transcription of RNA recovered 
from a stain. In addition, mRNA expression levels were compared between groups of 
blood donors of different age and also between the sexes. Evaluations of transcript levels 
were also performed to validate naturally occurring fluctuations in gene expression. 
Finally, blood stains collected every 4 hours for 24 hours were assessed using qPCR, for 
mRNA expression levels in order to identify genes exhibiting rhythmic patterns that 
could be referenced for time determination. 
Overall, results from the current study validate the feasibility of using gene expression 
during the circadian rhythm to further refine our ability to determine when, during a 24-
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 Forensic Science is a multidisciplinary field that encompasses many areas of 
Natural Sciences and has become an essential part of the judiciary system. The discipline 
of Forensic Biology has traditionally revolved around human identification from the 
examination of DNA sequences that vary within the human population (Jobling & Gill, 
2004). Although identifying the source of a crime scene sample is typically possible 
through DNA analysis, establishing the relevance of a biological sample(s) present at a 
scene to the crime that occurred there is presently not possible. For example, if the 
suspected perpetrator of a crime frequented the scene it might be expected that his/her 
DNA could be found there and not relevant to a crime whatsoever. Thus, correlation 
between the evidence and the crime can be critical in a criminal investigation. Being able 
to estimate the time a biological sample was created at a scene can link a crime to the 
evidence recovered at the site.     
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 Circadian rhythm is a 24-hour cycle that our body undergoes that is reflected in a 
repeated cycle of changing levels of mRNA and proteins. The central control of these 
biologic oscillations occurs via light signals that are received in the suprachiasmatic 
nucleus(SCN) of the hypothalamus (Cassone, Speh, Card, & Moore, 1988). This circadian 
control center in the brain, synchronizes the rhythms that exist in peripheral tissues (through 
synchronization of peripheral clocks) (Yoo et al., 2004). Although peripheral clocks are 
synchronized by the brain, there are exogenous factors that influence their rhythmic cycles. 
The first evidence that circadian rhythm existed in peripheral tissue was documented fifty 
years ago in Drosophila (Konopka & Benzer, 1971) and in the years that followed, scientists 
characterized the interaction of the central clock (within the hypothalamus) and the 
peripheral clocks (in tissues throughout the body) in mammals (Richards & Gumz, 2012) 
Remarkably, though peripheral rhythms foster coordinated physiologic activity, transcripts 
that oscillate in one tissue may not oscillate in another(Akhtar et al., 2002; Panda et al., 
2002). For this reason, it is necessary to characterize the circadian rhythm in a peripheral 
tissue if one wishes to understand the cyclic changes in physiology in that tissue. Thus, with 
respect to exploiting an understanding of the circadian rhythm for the estimation of the time 
of deposition of a blood stain, it is imperative to understand the characteristics of the rhythm 
in peripheral tissues. 
 While blood stains are a common biologic sample collected from a crime scene, 
defining circadian rhythm in blood stains is complicated by many factors. In addition to the 
fact one is analyzing a limited amount of dried blood, detecting a circadian rhythm of RNA 
quantity levels in blood is complicated by the presence of multiple cell lineages in the 
leukocyte population. The prospect that different cell types in the peripheral blood may 
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express circadian genes in different cyclic patterns presents a challenge to elucidating the 
circadian rhythm in blood. The possible existence of diverse patterns of gene expression in 
blood undoubtedly limits the sensitivity of any molecular assay designed to identify rhythmic 
pattern of gene expression that is not common to all lineages. In consideration of this 
confounder, researchers of circadian rhythm have isolated white blood cell populations in 
order to better define cyclic patterns. Published studies detail circadian rhythm data from 
research using isolated mononuclear or lymphocyte cell populations (Ackermann et al., 
2012). However, supplementary information, such as core body temperature and melatonin 
and cortisol levels, was necessary to accurately identify a rhythmic pattern (Ackermann et al., 
2012). Additionally, multiple blood samples from different collection times were needed for 
proper circadian assessment. Research reported in current literature use methods for data 
analysis for rhythmicity that involve complex equations incorporated with various 
normalizers for gene expression and graphic displays of data that suggest a rhythm from a 
chaotic collection of data points. Since physical separation of cell populations for analysis in 
a forensic blood stain is not feasible, an approach must be used that can either assess 
rhythmicity within the entire population of hematopoietic cells or is sensitive enough to 
detect rhythmicity in one cell line of interest. 
 The circadian rhythm studies published to date have also failed to identify variations 
in the circadian rhythm between the sexes, or age-related variations in the rhythm exhibited 
by whole blood without using additional information. Dried blood samples in the form of 
stains are typical types of crime scene evidence and therefore it is not possible to perform 
biochemical assays due to the increased rate of degradation of proteins. Core body 
temperatures can also not be obtained from a stain deposited as part of a crime. The ability to 
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define a circadian rhythm from a dried blood stain can provide important investigative 
information related to time that will assist with the reconstruction of a crime. In the study 
presented here, the quantification of RNA levels transcribed from a handful of genes that 
follow a predictable 24-hour pattern of expression holds the potential to estimate when, 






REVIEW OF THE LITERATURE 
 
 
 There are many useful applications of DNA/RNA testing for human identification 
in Forensic Science. There is a growing body of knowledge to correlate the degradation 
rates of nucleic acids to the time a body fluid was deposited at a crime scene. Researchers 
strive to extract additional information from tissues and body fluid stains retrieved from a 
crime scene using molecular tools in an effort to develop as complete an understanding as 
possible about the nature of the crime. Although human identification is possible through 
DNA analysis of a biologic stain recovered from a crime scene, in some cases the stain 
cannot be conclusively attached to the crime. In such cases, the correlation of the time of 
deposition for the stain with the commission of the crime could validate the evidentiary 
nature of the sample to the criminal investigation.  Circadian rhythm affords the 
possibility to identify a window of time in a biologic sample.  Current research involving 
the circadian rhythm centers around disease identification and treatment. Studies by 
forensic scientists involving the circadian rhythm have focused no changes in circadian 
6 
 
rhythm genes that correlate with the biologic age of an unknown suspect in an unsolved 
case rather than on the time a sample was deposited at a crime scene. Nonetheless, the 
possibility to exploit our understanding of the genes associated with the circadian rhythm 
would provide a means to estimate the time of day a biologic sample was deposited at a 
crime scene. The studies presented here investigate the feasibility of identifying rhythmic 
changes in genes associated with the circadian rhythm and exploiting those changes to 
estimate the deposition time of blood stains; a common type of forensic evidence.  
 
Forensic Science  
 Biologic evidence associated with a crime scene is often available in the form of 
trace amounts of dried samples deposited on a non-sterile matrix. It is the goal of the 
forensic scientist to associate the evidence with the crime in a way that advances an 
investigation and prosecution of a perpetrator. Analysis of forensic stains can proceed in 
different ways. For example, dried body fluid stains consist of numerous proteins, some 
of which represent genetic markers in the human population. However, analysis of 
specific proteins can be hampered by the small volume of body fluid composing the stain, 
as larger volumes may be required. In addition, analysis of proteins contained in a stain 
may be contingent on the matrix on which the sample is deposited. Environmental 
contaminants can also compromise the interpretation of data depending on the 
circumstances.  Finally, proteins tend to be labile molecules and degradation due to 
localized proteases may prevent detailed analysis of the evidence. 
  Melatonin is a hormone that is sometimes used in time-of-death estimates and 
one whose expression varies with the diurnal day-night cycle of the body. Melatonin 
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levels expressed over a 24-hour span and detected in the pineal gland, urine and serum 
can provide time of death estimates in corpses (Mikami et al., 1994). Degradation of 
melatonin due to exogeneous factors in a biologic sample renders the results useless. 
Although estimates of time are important in the time of death, the ability to estimate the 
age of an evidentiary stain recovered from a crime scene can also be important for 
advancing an investigation.  
 Nucleic acids are generally more resilient to external conditions than proteins and 
the analysis of genetic markers in chromosomal DNA has become the mainstay 
technology for forensic laboratories to conclusively identify individuals involved with a 
crime. DNA profiling has gained more credibility in court cases since its initial 
applications and was deemed “the new gold standard in forensic science” in 2003 (Lynch, 
2003). 
 The analysis of polymorphisms in human genomic DNA revolutionized Forensic 
Science. In the 1980’s restriction fragment length polymorphism Analysis (RFLP) was 
applied to criminal investigations (Gill, Jeffreys, & Werrett, 1985). DNA polymorphisms 
that exist in human genomic DNA include single nucleotide polymorphisms and tandem 
repetitions of short nucleotide sequences that are collectively known as VNTRs (variable 
number tandem repeats). RFLP analysis employs the use of restriction enzymes to digest 
chromosomal DNA into a complex mixture of fragments. If the restriction enzyme used 
does not make cuts to the DNA within VNTR loci, DNA fragments will be produced 
whose size is proportional to the number of tandem repeats contained within the tandem 
array.  Such fragments thus represent the alleles composing the DNA profile for the 
individual and, because of the high degree of variability exhibited by VNTR loci, 
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compelling evidence linking an individual to a crime can be produced. While RFLP-
VNTR methods were powerful as investigative tools for the investigation of crime, large 
amounts of intact DNA were required for the test method and evidentiary samples 
frequently yielded inadequate amounts of DNA for analysis, or the sample was 
environmentally damaged. Current forensic applications of DNA analysis exploit short 
tandem repeats (STR). STRs are heritable loci composed of variable numbers of repeated 
tetranucleotide or pentanucleotide sequences. As with RFLP-VNTR methods, alleles 
comprising the DNA profile of a sample are of variable length (as determined by the 
number of repeats harbored by an allele) but STR analysis benefits from the ability to 
amplify alleles using PCR. Thus, the STR typing method requires minute amounts of 
DNA and the DNA can be partially degraded and still produce probative results. Finally, 
STR typing can be performed with many of the steps involved being automated. 
Combined DNA Index System (CODIS), a national reference data base of STR profiles, 
was established by the FBI in 1996. STR results are used to compare suspect and crime 
scene samples or to find an unknown assailant. Criminal DNA evidence is submitted to 
CODIS in search of a match for identification of an unknown assailant or submitted to 
the bank for future references.  
 In addition to needing tools to answer the question of “who” in criminal 
investigations, it is sometimes important to an investigation to be able to answer the 
question “when”. For example, being able to estimate the age of an unknown perpetrator 
of a crime centers upon characterizing the lengths of telomers mapping to the ends of 
chromosomes that have been shown to shorten as one ages (Karlsson, Svensson, 
Marklund, & Holmlund, 2008). Another approach strives to evaluate changes in 
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methylation patterns that correlate with defined age groups (Hong et al., 2017; Horvath et 
al., 2012; Park et al., 2016). Methylation patterns for specific genes have also been 
associated with circadian rhythm particularly in brain tissue (Lim et al., 2014).  
 The determination of the length of time that has passed since a crime occurred can 
also be estimated through molecular testing. Fu and Allen (2019) developed a qPCR 
assay that characterized the degradation of several mRNA transcripts present in 
bloodstains stored over a span of 1 year and revealed that degradation proceeds in a 
predictable way that can be correlated with the age of the stain (Yu, Hazelton, Luebeck, 
& Grady, 2019). Using this assay, it is therefore possible to estimate the age of a blood 
stain such that its presence at a crime scene can be considered with respect to the time at 
which a crime occurred. 
 The ability to determine the time of day a crime occurred can also assist with an 
investigation. Genetic markers whose expression follows a circadian rhythm provide an 
opportunity to exploit and read the biological clock. For example, Kimura et al. (2011) 
quantified the expression of Period 2 (Per2), Brain and muscle ARNTL like protein-1 
(Bmal1) and Retinoic acid-related orphan nuclear receptor (Rev-Erbα) genes in mice 
immediately following sacrifice and up to 48 hours after death in kidney, liver and heart 
tissues. Results confirmed that mRNA levels of core circadian rhythm genes cease to 
change upon death.  In studies with human specimens, kidney, liver and heart samples 
from autopsied subjects that were less than 72 hours post-mortem were shown to harbor 
differing levels of RNA transcripts. Ratios of PER2 and BMAL1 mRNA were studied as 
possible markers for elapsed time. However, the rate of degradation for the two markers 
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differed and thus this approach was ineffective to accurately estimate time (Kimura, 
Ishida, Hayashi, Nosaka, & Kondo, 2011).  
 Current research strives to use circadian rhythm and DNA/RNA degradation rates 
to determine the time of death. In 2014 Lech et al. (2014) analyzed blood stains for 
microRNA (miRNA) degradation rates and tried to correlate rate changes with the 
deposition time for the stain. In this study miRNA 142-5 was analyzed and normalized to 
levels of miRNA 541. There was no correlation of degradation rates or rhythmicity 
detected (Lech et al., 2014). Martins et al. (2015) used quantification of nuclear DNA 
(nDNA) and mitochondrial DNA (mtDNA) in blood, hair and buccal swabs to estimate 
the time of day but failed to provide strong evidence that quantification of these DNAs 
was a viable approach to estimate time and stated “it is an expensive and more laborious 
methodology” and this approach could be used to “better predict if a STR analysis is 
viable” (Martins, Lima, Carvalho, Cainé, & Porto, 2015).  
 
Circadian Rhythm History 
 Chronobiology is the study of a rhythmic cycle seen in organisms exhibited on a 
consistent daily schedule and commonly referred to as circadian rhythm. Circadian 
rhythm is revealed through repeated patterns of behavior and biochemical changes over a 
defined period of time. Biologic rhythms have been observed in microorganisms, plants, 
and animals, many sharing homologous control genes (Bjarnason, Jordan, & Sothern, 
1999). Results from circadian rhythm research can be applied in numerous fields 
including cancer, psychological and sleep disorders, obesity, and forensic science. As 
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interest in this area increases so does the growing knowledge of the intricacies of the 
molecular clockwork of circadian rhythm. 
 The first evidence that circadian rhythm existed in peripheral tissue was 
documented in 1971 (Konopka & Benzer, 1971). These initial studies, using a mutant 
screening test in Drosophila flies, identified two genes (designated short period gene and 
long period gene) whose expression was regulated through light exposure during the 
day/night cycle (Konopka & Benzer, 1971). Subsequent research in mammals 
demonstrated a rhythmicity in gene expression in many peripheral non-neurologic tissues 
including mouse tongue, esophagus, stomach, jejunum, and rectal epithelium (Scheving, 
Burns, & Pauly, 1972). The bridge to human clock genes occurred when Bjarnason et al. 
(1999) analyzed levels of p53, cyclin-E, cyclin-A, cyclin-B1 and Ki-67 in human oral 
epithelium collected at 4-hour intervals.  Their data revealed a detectable circadian 
rhythm in gene expression that correlated with the cell cycle (Bjarnason et al., 1999).  
Likewise, Akashi et al. (2010) reported that expression of clock genes in human hair 
follicles followed a predictable circadian rhythm when gene expression data were 
analyzed through a cosinar curve fitting analysis. (Akashi et al., 2010). Elucidation of 
circadian rhythms became plausible when expression of putative circadian markers was 
considered with additional clinical observations, such as core body temperature, and 
blood levels of melatonin and cortisol. For example, research elucidating elements of the 
circadian rhythm in human white blood cells, adipose tissue and skin epithelium has been 
possible considering core body temperature and melatonin levels that vary with light and 
dark cycles (Cermakian & Boivin, 2009). In  peripheral blood, lymphocytes in particular, 
the rhythmic expression of cellular markers has been shown to be correlated with 
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cytokine production suggesting a link between the circadian rhythm and immune function 
(Born, Lange, Hansen, Mölle, & Fehm, 1997).  
 The demonstration of circadian rhythm gene expression in peripheral blood has 
made it feasible to easily study circadian rhythm in humans. The use of peripheral blood 
is less invasive, and samples are more readily obtainable when compared with tissue 
biopsies. Regrettably, the use of peripheral blood also introduces a confounder for data 
interpretation inasmuch as the different cell populations comprising the leukocyte 
fraction of blood could exhibit dissimilar levels of clock genes expression. Thus, 
scientists separated the different blood cell populations to more accurately analyze cyclic 
patterns. Peripheral blood mononuclear cells became more widely used in many research 
laboratories for circadian rhythm investigations. In 2005, one study evaluated male 
subjects in normal and altered light environments to imitate conditions of shift workers. 
Results were compared against core body temperature, melatonin and cortisol levels, 
whose values were normalized to the expression of the β actin gene. Significant 
variations in gene expression were observed between groups experiencing normal versus 
altered light environments (Takimoto et al., 2005). In another study, blood from young 
males was collected every 2 hours and the raw data were normalized with core body 
temperatures, melatonin and cortisol levels or by using relative levels of mRNA. The 
normalized results were analyzed using the cosine model mentioned previously. In this 
study, only 3 of 10 genes (PERIOD 1, 2, and 3) were found to exhibit a circadian rhythm. 
(Kusanagi et al., 2008).   
 There have been numerous studies employing a wide range of experimental 
approaches and sample types. It would be useful in forensic science and in medicine if a 
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circadian rhythm could be identified at the gene expression level in peripheral blood. 
Blood is a common type of forensic evidence recovered from crime scenes and blood is a 
typical sample for medical diagnostic tests. However, as it stands now, no well-defined 
circadian rhythm has been defined in peripheral blood, perhaps because of the complexity 
in cell populations comprising blood.  
 
Circadian Rhythm Physiology 
 Multiple environmental cues (known as “zeitgebers”) drive or maintain a 
consistent cyclic rhythm. Light acts as an external cue through the suprachiasmatic 
nucleus (SCN) in the anterior hypothalamus. Light is perceived by the retinal 
photosensitive pigments (i.e., melanopsin) that in turn transmit signals by the retinal 
ganglion cells (Albrecht & Eichele, 2003) via the retinohypothalamic tract to the SCN 
(Güler et al., 2008). The SCN contains more than 100,000 neurons (Cassone, Speh, Card, 
& Moore, 1988) which mediate the light signal through the levels of glutamate and 
pituitary adenylate (Albrecht & Eichele, 2003). The SCN is credited with directing and 
maintaining synchrony between peripheral oscillators throughout the body and is deemed 
the “master clock” (Okamura et al., 1989). Light, perceived in the SCN, controls the 
production of melatonin in the pineal gland. Melatonin levels in turn drive sleep cycles, 
which in turn affect the peripheral oscillators through melatonin receptors (MT1 and 
MT2) that modulate metabolism, cell cycle, and arterial vasoconstriction (Dubocovich & 
Markowska, 2005). Stability of the rhythm is supported by the natural resistance to 
changes in sleep and activity patterns (Scheer, Pirovano, Van Someren, & Buijs, 2005). 
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 Peripheral oscillators are driven by activity, sleep patterns, eating and temperature 
but are kept in check by the SCN (Damiola et al., 2000). In addition to changes in the 
levels of gene expression, epigenetic modifications provide an additional level of control 
of rhythmic gene expression. The molecular control over gene expression exists in 
peripheral organs such as in the liver, kidneys and fibroblasts (Yamazaki et al., 2000). 
Scientific evidence supports the existence of tissue microenvironments with differing 
circadian rhythms controlled by multiple peripheral clocks in an organism (Liu, Cai, 
Sothern, Guan, & Chan, 2007).  These peripheral rhythms vary from site to site and can 
be demonstrated in oral epithelium (Bjarnason et al., 1999), peripheral blood (Teboul et 
al., 2005), vitreous humor (Corradini et al., 2015), and liver (Cermakian & Boivin, 2009), 
but differ from rhythms in the various areas of the brain (Abe et al., 2002). Peripheral 
clocks also exhibit sensitivity to zeitgebers, such as changes in feeding schedules and 
temperature (Damiola et al., 2000; Hara et al., 2001). They can function independently of 
the SCN for a short period of time, as observed in tissue cultures (Balsalobre, Damiola, & 
Schibler, 1998). The plasticity of the peripheral oscillators adapts to the aforementioned 
zeitgebers, and changes in gene expression can be accompanied by post-translational 
modifications to fine-tune the expression pattern in a tissue specific manner. Although 
the patterns vary tissue to tissue, the master clock controller remains in the SCN.  
Research utilizing microarray technology suggests that ten percent of all genes are 
expressed in a circadian pattern and are clock controlled (Masri & Sassone-Corsi, 2010). 
Transcription factors, ion channels, peptides, and metabolic enzymes are encoded by 
clock genes (Duffield, 2003) and are cyclically expressed. Core clock genes encode 
protein products that are necessary to generate and maintain the circadian rhythm. These 
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core clock genes are expressed in many tissue types, with higher levels of expression in 
the SCN. Core clock genes include Brain and Muscle ARNTL-like protein-1 (BMAL1), 
Circadian Locomotor Output Cycles Kaput (CLOCK), PERIOD1 (PER1), PERIOD 2 
(PER2), PERIOD 3 (PER3), CRYPTOCHROME 1 (CRY1), and CRYPTOCHROME 2 
(CRY2).  
 
CLOCK/BMAL1 and E-boxes 
A complex, fine-tuned series of control mechanisms drive and maintain circadian 
physiology synchrony. There are two central transcription factors that initiate and sustain 
rhythmicity. Brain and Muscle ARNT-Like 1 (BMAL1) and Circadian Locomotor 
Output Cycles Kaput (CLOCK) proteins act as the central conductors of a circadian 
rhythm symphony. BMAL1 and CLOCK heterodimerize and bind to E-box activation 
sites on select genes (PER1-3 and CRY1-2 genes) to initiate transcription (Gekakis et al., 
1998). A Per/Cry protein heterodimer forms in the nucleus and disrupts the 
BMAL1/CLOCK heterodimer in a negative feedback fashion, down regulating 
transcription (Lee, Etchegaray, Cagampang, Loudon, & Reppert, 2001). Additional 
regulators of the BMAL1/CLOCK heterodimer include nuclear receptor subfamily 1 
Group D number 1 (REV-ERBα) and retinoic acid receptor-related orphan receptor alpha 
(RORα) which are also transcriptionally regulated by BMAL1/CLOCK heterodimers via 
E-box binding. REV-ERBα blocks transcription of BMAL1 whereas RORα activates 
BMAL1 transcription as it binds to RORE (retinoic acid-related orphan response 




 CLOCK and BMAL1 exhibit a basic conformational structure known as basic 
helix-loop-helix (bHLH) (Hogenesch et al., 1997). Specific areas within these proteins 
exhibit 35% homology involving 60 amino acid residues in 3 domains (Huang et al., 
2012). This complementarity of the amino acids between the two proteins (BMAL1 and 
CLOCK) allows for the formation of homodimers and heterodimers. [Figure 1] Several 
key amino acid residues within homodimer domains exhibit pronounced side-chain 
clashes that result in unstable structures. Within identical domains, Phe50 in CLOCK and 
His84 and Leu125 in BMAL1 promote these discordances (Wang, Wu, Li, & Su, 2013). 
This incompatibility creates a steric hinderance within these domains that reduces 
homodimer development and creates a preference for heterodimer formation. Hydrogen 
bonds form a stable connection between BMAL1 and CLOCK via five identified 
recognition sites within the helical structures. Among these five key positions, CLOCK 
His84 and BMAL1 Leu125 are the key recognition sites between bHLH structures of 
CLOCK and BMAL1 (Wang et al., 2013). The CLOCK/BMAL heterodimer is the 
primary transcriptional activator in the circadian clockwork.  
 A stable BMAL/CLOCK heterodimer can bind enhancer box (E-box) response 
elements in a variety of genes. Thus, the presence of E-box sites in DNA promoter 
regions provide strong evidence that these genes likely play a role in circadian rhythm. 
An E-box is a DNA response element that facilitates transcription upon activation. The 
6bp recognition sequence often exhibits a nucleotide sequence palindrome of CACGTG 
(Bellet & Sassone-Corsi, 2010) and E-box sequences exhibit no appreciable observed 
degenerate recognition sites. Consequently, the lack of degenerate sequences provides 
evidence that each residue reacts with each site. Recent work by Wang et al. 
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demonstrates CLOCK Arg39, Glu43, Arg47 and BMAL1 His77, Glu81, Arg85 are the 
key residues that bind to the CACGTG E-box sequence for transcriptional activation 
(Wang et al., 2013). 
 
                                         
Figure 1. Human CLOCK/BMAL1 Heteroduplex. Both molecules contain interacting 
basic helix-loop-helix (bHLH) domains that interact with target DNA (Wang et al., 
2013). Image with permission from Springer Nature Publishing. 
 
PERIOD and CRYPTOCHROME Transcripts 
 In the circadian rhythm system, binding of the BMAL1/CLOCK heterodimer with 
an E-box provides accessibility to promoters to allow transcription of negative regulators 
of core clock genes (Gekakis et al., 1998). Thus, the BMAL1/CLOCK heterodimer 
reduces or eliminates expression of genes central to the circadian rhythm. These negative 
regulators include: PERIOD 1 (PER1), PERIOD 2 (PER2), and PERIOD 3(PER3) that 
are members of the Period family of genes (Sangoram et al., 1998). Other negative  
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regulators include CRYPTOCHROME 1 (CRY1) and CRYPTOCHROME 2 (CRY2), 
members of the Crytpochrome family of genes (Kume et al., 1999). These negative 
regulators accumulate in the cytoplasm of the cell and interact with components 
associated with circadian rhythm, metabolism and behavior.  Period genes were the first 
circadian rhythm genes discovered and were identified in Drosophila (Konopka & 
Benzer, 1971). The expression of the Drosophila period genes Period and Timeless is 
activated in response to interaction of the genes with heteroduplex BMAL1/ CYCLE 
(Houl, Yu, Dudek, & Hardin, 2006). Mammalian homologs were soon identified as 
Period 1-3, Cryptochrome 1-2 and the positive inducer BMAL/CLOCK heterodimer. 
 The complexity of the regulatory network surrounding the circadian rhythm is 
slowly emerging (Jagannath, Taylor, Wakaf, Vasudevan, & Foster, 2017). Period and 
cryptochrome proteins can exist singly or as heterodimers. These proteins accumulate in 
the cytoplasm and phosphorylation patterns determined their fate. Mammalian models 
provide evidence that core circadian rhythm proteins are phosphorylated via casein 
kinase 1 epsilon (CK1ε) and casein kinase 1 delta (CK1δ). Phosphorylation of a 
PER/CRY protein heterodimer facilitates reentry of the complex into the nucleus where 
the phosphorylated complex disrupts the BMAL1/CLOCK heterodimer and interferes 
with the subsequent binding of BMAL/CLOCK to E-box response elements. Following 
disruption of the binding of BMAL1/CLOCK, transcription of additional Period and 
Cryptochrome mRNA is halted (Gallego & Virshup, 2007). Unbound period proteins are 
targets for phosphorylation by the kinases described above and then become targets for 
removal from the cell through ubiquitination with ultimate proteasomal degradation in 
the cytoplasm (Zhou, Kim, Eng, Forger, & Virshup, 2015). Excess cytoplasmic 
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cryptochrome levels are controlled through a different ubiquitin protease-signaling 
pathway. Once the period and cryptochrome proteins decrease in the cytoplasm, transport 
of these proteins into the nucleus diminishes as well and the BMAL/CLOCK heterodimer 
is again available for transcriptional activation via E-box interactions. The symphony of 
gene expression patterns that support the circadian rhythm are diagrammatically 




Figure 2. Molecular Components of the Core Clock. A network of transcriptional-
translational feedback loops constitutes the mammalian circadian clock (Ko & Takahashi, 





Clock Controlled Markers 
 The core clock components (BMAL1, CLOCK, Period 1-3, Cryptochrome 1-2) 
are the first level of control in circadian rhythm. CLOCK and BMAL1 are activated in the 
morning with subsequent activation of Per1-3 and Cry1-2. Thus these genetic markers 
share very similar daily patterns of expression exhibiting peak levels of expression in the 
morning that slowly diminish throughout the day (Takahashi, 2017). Accurate assessment 
of circadian rhythm requires multiple markers that exhibit different expression peaks and 
troughs. It is expected that analysis of multiple markers on one sample could increase the 
sensitivity and accuracy of circadian rhythm determination. Thus, the use of additional 
markers associated with peripheral clocks allows a more dynamic circadian rhythm 
analysis. The circadian rhythm exhibited by peripheral organs is separate from the 
suprachiasmatic nucleus (SCN) but the rhythmicity is coordinated through the core clock 
genes. Additional exogenous stimuli contribute rhythmicity to various tissue types and 
molecular markers have been implicated in these processes. These supplementary 
rhythmic genes provide additional opportunities to determine time points in rhythmicity 
while remaining responsive to SCN oversight. 
 
Cyclin E (CYE) 
 The eukaryotic cell cycle exhibits four phases that include gap 1(G1), DNA 
synthesis(S), gap 2(G2), and mitosis(M). The cell cycle is tightly regulated via cyclin 
proteins that fluctuate daily levels of proteins that coincide with observed cellular 
proliferation. Cyclin D, E, and A regulate progression from G1 to S phase while cyclin 
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B1 regulates G2 to M phase transitions (Sherr, 1994). (see Figure 3) Cyclin proteins are 
activated through phosphorylation by cyclin dependent kinases (cdk) (Morgan, 1997; 
Solomon, 1993) that in turn, are inhibited in their kinase activity by cdk inhibitors 
(Hengst, Dulic, Slingerland, Lees, & Reed, 1994). Circadian rhythm patterns have been 
observed in mouse gastrointestinal tissue, bone marrow and corneal epithelium (Scheving 
et al., 1972; Scheving, Burns, Pauly, & Tsai, 1978).  Likewise, the association of the 
circadian rhythm involvement with the cell cycle has been documented in human rectal 
mucosa (Buchi, Moore, Hrushesky, Sothern, & Rubin, 1991), oral mucosa 
(Warnakulasuriya & MacDonald, 1993) and bone marrow (Smaaland et al., 1991).  
 The ability to identify and define a circadian rhythm as it relates to time and cell 
function provides a useful tool both in disease treatment and also perhaps in forensic 
studies. Bjarnason et al. attempted to predict the time of day based on expression levels 
of cyclin proteins A, B1, and E, p53 and Ki67 in human oral epithelium through a single 
cosinor method of analysis (Bjarnason et al., 1999). Their data reinforced the notion that 
detection of the circadian rhythm at the molecular level was feasible although their 




Figure 3. Cyclin Proteins Involved in the Cell Cycle. Cyclin proteins play an important 
role in each stage of the cell cycle. 
(http://www.cancerbiomed.org/index.php/cocr/article/view/1070/1194) 
 
Map Kinase Interacting Serine/Threonine Kinase 2 (MKNK2) 
 MKNK2 is a calcium/calmodulin-dependent protein kinase that is activated 
(phosphorylated) by mitogen-activated protein (MAP) kinases (Waskiewicz, Flynn, 
Proud, & Cooper, 1997). MKNK2 appears to be influenced by exogenous factors first 
detected in studies where changes in sleep patterns did not alter expression levels (Lech 
et al., 2015). Subsequently, phosphorylated MKNK2 directly phosphorylates eukaryotic 
initiation factor-E (eIF4E) that in turn plays an important role in hematopoiesis (Gorentla 
et al., 2013) and cellular apoptosis (Chrestensen et al., 2007). Recent data has 
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demonstrated that peripheral blood mononuclear cells exhibited a rudimentary 
rhythmicity of MKNK2 when normalized to levels of beta actin (ACTB) mRNA  in the 
cells (Lech et al., 2015). Therefore, there is strong evidence that MKNK2 in peripheral 
blood may prove to be a valuable marker for defining the circadian rhythm in 
hematopoietic cells.   
 
Thyroid Receptor Alpha 1 (THRA1) 
 THRA1 is a thyroid hormone receptor in a nuclear receptor superfamily that is 
involved with control of transcription (Flamant et al., 2006). THRA1 levels are 
exogenously affected by the effect food intake has on gene expression in the liver. 
THRA1 expression therefore tends to be diurnal with higher levels existing during waking 
hours and the lowest levels during sleep. (Doulabi et al., 2004). The study of a rhythmic 
marker whose expression is influenced by something other than light offers the chance to 
study an alternate to light-controlled circadian rhythm. THRA1 levels were found to 
exhibit a regular, consistent repeating pattern of abundance over a 24-hour period in 
peripheral blood mononuclear cells. In these studies, THRA1 levels were normalized to 
the expression of the beta actin gene (Lech et al., 2015). Studies of rhythmic gene 
expression that are influenced by light and other stimuli affords the opportunity to expand 
the depth of our understanding of the circadian rhythm and to possibly exploit that 
knowledge for estimating time. 
 
Tryptophan Hydroxylase (TPOH) 
 Melatonin is the primary hormone produced by the pineal gland that exhibits daily 
rhythms controlled by the SCN (Reiter, 1993). Levels of melatonin increase during 
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nocturnal phases and diminish during photoperiods resulting in the transmission of 
circadian information throughout the body (Goldman, 1999).  Tryptophan Hydroxylase 
(TPOH) metabolizes tryptophan in a biochemical pathway that produces melatonin 
(Lovenberg, Jequier, & Sjoerdsma, 1967). The expression of the TPOH gene appears to 
play a pivotal role for the rhythmic expression of melatonin inasmuch as the TPOH 
protein exhibits a very short half-life. (Sitaram & Lees, 1978). Besancon et al. and 
Shibuya et al. showed parallel levels of Tpoh gene expression and enzyme activity during 
the day that peaked during the evening hours (Besançon, Simonneaux, Jouvet, Belin, & 
Fèvre-Montange, 1996; Shibuya, Toru, & Watanabe, 1977). Melatonin is a well-
documented analyte exerting regulation of the circadian rhythm in concert with core body 
temperature and serum cortisol levels in living organisms (Skene & Arendt, 2006). The 
application of melatonin quantitation methods to biologic material studied in forensic 
investigations is limited because of marker stability and because of the inability to 
evaluate core body temperature. It is possible quantifying levels of TPOH mRNA may 
prove useful as a molecular marker with which to study the circadian rhythm.  
 
Epigenetics and Molecular Modifications 
Knowledge of the nucleotide sequence of a gene is not the only determinant 
affecting gene expression. Epigenetics roughly translates as “on top of genetics” meaning 
molecular interactions between genome and regulatory factors exist as an additional 
regulatory facet of gene expression. These epigenetic influences are heritable and do not 
alter the nucleotide sequence. Epigenetics has always been a possible source of control of 
the circadian rhythm in addition to the feedback described above that is related to factors 
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that interact with regulatory elements of select genes. Epigenetic modifications include 
biochemical modifications of DNA such as methylation and modifications of histone 
proteins through acetylation, methylation and phosphorylation. Modifications such as 
these can collectively be called acquired modifications. Inherited and acquired 
modifications of DNA sequence therefore control gene expression and alterations in the 
normal modification patterns are linked to a wide range of diseases.   
 
DNA Modifications 
Methylation is highly conserved and can be detected in organisms throughout 
eukaryotic organisms from Neurospora (Belden, Lewis, Selker, Loros, & Dunlap, 2011) 
to brain tissue of human cadavers (Nakatome et al., 2011). DNA methylation is a 
widespread heritable pattern of DNA modification whereby methyl groups are most 
commonly added to the C5 position of a cytosine residue by methyltransferases. This 
methylation most often occurs in CpG islands composed of 50% or greater of GC base 
pairs. CpG islands are typically found near promoter regions and thus methylation can 
alter transcription through promoter accessibility. Methylated DNA can also be found 
within coding sequences where alternate promoter regions may exist. (Gardiner-Garden 
& Frommer, 1987). Methylation is most often thought of in the context of X-
chromosome inactivation or with regulation of gene expression although recent advances 
suggest the association of methylation changes with carcinogenesis and aging. 
Synchronous patterns of methylation also exist and produce transcriptional oscillation for 
genes involved with the cell cycle that is part of the circadian clock (Brown, Fraga, 
Weaver, Berdasco, & Szyf, 2007). Cai et al. showed that core circadian rhythm genes 
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exhibited methylation patterns in select E-box regions of mPer1 in mouse liver, thymus 
and testis (Cai et al., 2009). Similarly, Zhang, et al. analyzed clock genes in human 
leukocytes for methylation changes associated with aging (L. Zhang, Lin, Ding, Wang, & 
Cai, 2012). Since methylation changes have been verified for core clock genes that 
exhibit expression rhythmicity, it is possible these waves of gene expression can be used 
forensically to learn about biological evidence recovered from a crime scene. 
 
Histone Modifications  
A nucleosome is a fragment of genomic DNA approximately 146 base pairs in 
length wound around a histone octamer involving pairs of core histone proteins, i.e., 
H2A, H2B, H3, and H4 (Luger, Mäder, Richmond, Sargent, & Richmond, 1997). A 
nucleosome functions to compact and repress gene expression and is often associated 
with heterochromatin. The unwinding of the DNA from a nucleosome converts 
heterochromatin to euchromatin that has more relaxed and accessible structure 
compatible with gene expression. Histone modifications assist with controlling the 
conversion of heterochromatin to euchromatin and back again and provide an additional 
layer of transcriptional control. There are various types of chemical modification to 
histones that have been described but those modifications thought involved with 
circadian rhythm include acetylation, phosphorylation, and methylation (Crosio, 
Cermakian, Allis, & Sassone-Corsi, 2000; Etchegaray, Lee, Wade & Reppert, 2002; 
Masri & Sassone-Corsi, 2010; Ripperger & Schibler,2006).   
 The type of histone acetylation that has been extensively examined involves the 
addition of an acetyl group to a lysine residue in the N-terminal tail of histones 
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H2A,H2B, H3 and H4 (Kuo & Allis, 1998). The addition of an acetyl group removes the 
positive charge from the histone which in turn decreases the interaction with the 
negatively charged phosphate group of the DNA backbone and allows genes to assume a 
more relaxed structure that is more accessible for transcription (Mutskov et al., 1998). 
Within the circadian rhythm controls, the CLOCK polypeptide exhibits histone 
acetyltransferase activity (HAT) when bound to an E-box as a heterodimer with BMAL1 
(Doi et al., 2006; Etchegaray et al., 2002). The acetylation of H4 histones frees up the 
promoters at the E-box genes thus increasing transcription (Frank, Schroeder, Fernandez, 
Taubert, & Amati, 2001). Additionally, acetylation of BMAL1 enables CRY-dependent 
repression of the CLOCK/BMAL1 heterodimer (Hirayama, et al., 2008). The histone 
deacetylase activity (HDAC) of BMAL1 reverses the effects of an acetyl group thus 
allows the repressor to bind and reduce transcription. SIRT1 (silent mating type 
information regulation type 2 homolog 1) also acts as a HDAC to circadian rhythm 
machinery. The oscillating characteristic of SIRT1 is linked to NAD+/NADH levels that 
link cellular energy metabolism to circadian rhythm (Asher et al., 2008; Imai, Armstrong, 
Kaeberlein, & Guarente, 2000).   
Histone phosphorylation is achieved through an array of different kinases that 
target serine, threonine or tyrosine residues in the polypeptide chain. Phosphate groups 
are removed from histones through the action of phosphatases. Phosphorylation of 
histones initiates remodeling of the chromatin which, of course has consequences for 
gene expression. Light is one of the main driving forces in the circadian rhythm and the 
connection between a light stimulus and the rhythmic cycling of cell physiology provides 
an important connection between the environment and circadian rhythm. Light-directed 
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histone remodeling was discovered in the suprachiasmatic nucleus (SCN), the circadian 
pacemaker, where exposure to light caused rapid phosphorylation of histone 3 on serine 
residue #10 associated with the c-fos and Per1 genes (Crosio, Cermakian, Allis, & 
Sassone-Corsi, 2000). The histone remodeling response to light exposure provides 
support for the notion of light entrainment. Phosphorylation acts as an intermediate 
modification in the histone code and functions to condense the chromatin during cell 
division, regulate transcription and serve as a recruiting point for DNA repair 
mechanisms (Lowndes & Toh, 2005; Rossetto, Avvakumov, & Côté, 2012). 
Histones can also be methylated which involves the addition of a methyl group to 
a lysine or arginine in the N- terminal tail of histones H2A, H2B, H3, and H4. The 
residue that is methylated determines if transcription is blocked or enhanced. Histones 
can be mono-,di- or tri-methylated that in turn determines the effect on transcription (Y. 
Zhang & Reinberg, 2001). There is no consistent effect of any specified histone 
methylation pattern on transcription, the effect is defined by the residues modified and 
the presence of other modifications on that histone. The enzyme histone 
methyltransferase transfers methyl groups to histones while histone demethylases remove 
the methyl group (Shi et al., 2004). 
The amalgamation of these biochemical modifications constitutes the histone 
code. The histone code reflects the combination of modifications that dictate the final 
transcriptional state of a genomic region. Histone modifications are assessed through 
mass spectrophotometry and immunoprecipitation assays. Although histone 
modifications exhibit a cyclic pattern and are connected to light stimuli, metabolism and 
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cell cycle, the ability to assess histone modifications in a forensic sample is not feasible 
due to sample quality and volume limitations. 
 
Non-Coding RNA 
Non-coding RNAs (ncRNA) are untranslated transcripts that exhibit regulatory 
functions at the posttranscriptional level. There is increasing evidence that ncRNAs play 
a large role in epigenetic control (Wei, Huang, Yang, & Kang, 2016). Non-coding RNAs 
are classified by function into housekeeping or regulatory categories. The regulatory 
ncRNAs can be further classified as short chain non-coding RNA (including small 
interfering RNA [siRNA], microRNA [miRNA], and piRNA [piwi interacting RNA] and 
long non-coding RNA [lncRNA]. Non-coding RNAs interact directly with mRNA or 
indirectly through epigenetic mechanisms to alter expression through binding or 
recruitment of acetyl and methyl groups for histone modifications (Peschansky & 
Wahlestedt, 2014). Diseases are linked to alterations in gene expression that may be due, 
in part, to quantitative changes in ncRNA. Tani et al. observed variable expression of 
ncRNA in human clonal cultures when exposed to different environmental factors (Tani 
& Torimura, 2015) thus linking pathogenesis to exogenous influences. 
Vast differences exist in research pertaining to ncRNA applications. Short 
interfering RNAs are useful as a knockout method in cell culture. Vollmers et al. used 
siRNA to knockout BMAL1 and Cry1 in human cell cultures to further investigate the 
core clock interactions (Vollmers, Panda, & DiTacchio, 2008). Differentiating night from 
day in a forensic study was published by Lech, et al (2015). In this study, RNA was 
extracted from 400 µl of whole blood. Markers that had previously shown differences in 
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levels in victims that had died during the day or nighttime were assessed (miRNA 142-5 
and miRNA 541). Results were normalized to miRNA 222 abundance. No discernable 
pattern of ncRNA expression was detected in this study although in vitro miRNA 
stability was observed (Lech et al., 2014). Later research attempted to correlate miRNA 
with circadian rhythm using 92 miRNA markers from fresh plasma samples (Heegaard et 
al., 2016). Rhythmicity in abundance was detected in 26 of the miRNAs when the data 
was analyzed using the cosinor method without an established normalizer (Heegaard et 
al., 2016). Results from this study provided evidence of miRNA oscillation but the lack 
of a normalizing marker and the possible instability of miRNA retrieved from a crime 
scene limits the utility of ncRNA assessment in forensic evidence at this time.  
 
Circadian Rhythm Disorders 
 An understanding of the circadian rhythm can be powerful knowledge for 
applications in many scientific disciplines. The complexity of the rhythmic physiology 
that is the circadian rhythm creates opportunities to apply an understanding of the process 
to the diagnosis and treatment of a pathologic condition or perhaps even identifying a 
moment in time. Physiological changes that accompany some diseases result in an 
abnormal circadian rhythm. Changes in sleep patterns and variations in light exposures 
can disrupt normal rhythmicity and also promote an increased incidence of disease. 
Genetic mutations occurring in genes whose expression cycles, or molecular 
modifications to those gene products can also contribute to an abnormal circadian 
rhythm. Changes in the circadian rhythm can negatively impact normal functioning 
including sleep cycles, metabolism, hormone levels and cell cycles. 
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 Light acts as an external influence on circadian rhythm both in the core clock and 
in peripheral clocks. Light perceived through specialized ganglia in the retina dictates the 
level of melatonin that circulates and influences oscillations throughout the body. 
Melatonin levels serve to synchronize the peripheral systems. Alterations in the length 
and timing of light exposure affects normal circadian rhythm (Wright et al., 2013). 
Disruptions to the normal rhythm have been associated with disorders such as 
cardiovascular disease due to atherosclerosis (Schilperoort et al., 2020). Metabolic 
disruptions (Skinner, Rizwan, Grattan, & Tups, 2019), and atypical emotional conditions 
(Stephenson, Schroder, Bertschy, & Bourgin, 2012) are also linked to circadian rhythm 
abnormalities. Furthermore, energy consumption is linked to circadian rhythm through 
metabolic sensors such as SIRT1, a histone deacetylase, that acts as an energy sensor via 
NAD+ levels. When NAD+ levels are increased SIRT1 activity is increased that 
deacetylates histones at clock promoters interacting with BMAL1 and PER2 thus 
affecting circadian rhythm (Asher et al., 2008; Imai et al., 2000; Nakahata, Sahar, 
Astarita, Kaluzova, & Sassone-Corsi, 2009). Alterations in these core clock components 
can have a wide-spread downstream effect on physiologic homeostasis.   
 Nucleotide sequence polymorphisms in clock genes are also associated with 
metabolic abnormalities, mood disorders, atypical sleep cycles, and schizophrenia. The 
transcriptional activity of clock genes and the action of their gene products influence all 
areas of the body. So, deviations from the norm that alter circadian rhythm can have wide 
ranging physiological effects.  
 There are numerous disorders that are linked to aberrant rhythms. One such 
example is Familial Advanced Sleep Phase Syndrome (FASPS) that results from a serine 
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to glycine amino acid change in a phosphorylation site on the Per 2 gene (Gekakis et al., 
1998). Characteristics of FASPS include life-long accelerated sleep cycles that typically 
begin at 7:30pm and end at 4:30am. 
 Recent studies have shown that shifted sleep patterns are also sometimes 
associated with cancer. Sleep cycles and cell cycles exhibit a circadian rhythm. Thus, if a 
circadian rhythm abnormality is present, it is likely that other peripheral circadian rhythm 
(CR) systems are affected as well. In cancer, malignant cells exhibit a high mitotic 
activity that is associated with an increase in the population of abnormal cells. In 2002, 
researchers successfully correlated circadian rhythm disturbances in cell cycle genes with 
cancer in mice (Filipski et al., 2002). Further research connected atypical sleep patterns 
with an increased incident of metabolic (Sahar & Sassone-Corsi, 2009) and breast 
cancers (Schernhammer et al., 2001; Wegrzyn et al., 2017).  P53, a tumor suppressor 
gene, regulates cell division and plays a critical role in detection and repair of damaged 
DNA. P53 also exhibits a circadian rhythm in its expression and so it might be expected 
that abnormalities in P53 expression are associated with over 50% of human cancers 
(Schmitt et al., 2002).  
 Atypical epigenetic modifications of key clock genes have also been implicated in 
pathologic conditions such as the abnormal activity of methyl transferase on the cytosines 
in the promoter region of per1, per2, and per3 (Chen et al., 2005). Abnormal methylation 
results in unregulated cell division in breast cancer. 
 There is an abundance of literature that demonstrates it is possible to detect and 
quantify levels of gene expression that accompany progression through the circadian 
rhythm. The question arises as to whether it might be possible to use rhythmic gene 
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expression as a forensic tool to estimate the time of day biologic evidence was created 
and deposited at a crime scene. In previous work from this laboratory, Fu and Allen 
(2019) demonstrated that it is possible to estimate the age of a body fluid stain to within 
2-4 weeks of its actual age. Extending this research, it might be possible to use changes in 
gene expression, based on circadian rhythm, to determine the time of day a body fluid 
stain was created. Two mRNA transcripts from among many studied followed a 
predictable 24-hour cyclic pattern of expression in blood stains that show promise as 









Institutional Review Board (IRB) 
IRB approval #2018010 April 24, 2018. 
IRB protocol was followed for the collection and handling of all venous and capillary 
samples collected for this research. (Appendix A) 
 
METHYLATION STUDIES 
Donor Selection for Methylation Study  
 This study was designed to determine if a 24-hour rhythmic pattern of DNA 
methylation could be detected in peripheral blood. Individual donors over the age of 18 
were randomly chosen with one contingent; volunteers were required to have normal 
sleep patterns. A normal sleep pattern was defined as routine sleep cycles beginning after 
8:00 pm and ending after 5:00 am with a minimum of 6 hours of sleep within that time 
frame.  Donors exhibiting a “normal sleep pattern was defined as routine sleep cycles  
beginning after 8:00 pm and ending after 5:00 am with a minimum of 6 hours of sleep
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within that time frame.  Donors exhibiting a “normal sleep pattern” were chosen in the 
hope of establishing reference methylation patterns in a normal population. Once normal 
sleep cycles were confirmed in a donor, volunteers signed consent forms (Appendix B) 
that clarified collection details with possible complications, had the testing protocols 
explained and were subjected to de-identification practices. Each volunteer also 
completed a survey (Appendix C) with questions pertaining to normal waking hours to 
support their selection for the study. Daily exposures to natural and artificial light, eating 
schedules and any use of sleep aides were also investigated for each donor.   
 
Blood Collection for Methylation Study 
 All capillary and venous blood samples were collected from volunteers. 
Collections were performed by trained and/or certified medical professionals. Fingerstick 
capillary blood was collected every 4 hours over a 24-hour period. Sample collection 
began at 8:00 am and was completed at 4:00 am. Collecting the final sample at 4:00 am 
established the least expected interference with normal circadian routines during the 
collection period. Fingerstick samples for capillary blood were performed with 
SurgiLance™ 2.8 mm 21-gauge safety lancets (MediPurpose™, Duluth, GA). Capillary 
samples were spotted in a minimum of a 20 mm circumference onto sterile and nuclease-
free 705™ Classic Specimen Cards (Fitzco®, Spring Park, MN). Although there is no 
literature to support complications, anticoagulant was avoided to circumvent possible 
interference with methylations studies. Specimen cards were stored in the dark at room 





DNA Extraction for Methylation Study 
 Extractions were performed after 6 samples, representing a 24-hour day, were 
collected from each donor. Extractions were performed within 48 hours of the first 
fingerstick. Dried blood stains from specimen cards were cut into small 1-2 mm strips 
and placed into microfuge tubes. Cellular and nuclear membranes were lysed, and 
proteins degraded using an extraction buffer containing 100 µg/mL of proteinase K, 0.5% 
(v/v) sodium dodecyl sulfate in TNE Buffer (50 mm Tris–HCl (pH 7.4) with 200 mM 
NaCl and 0.1 mM EDTA). Following lysis, samples were subjected to extraction with 
phenol/chloroform/isoamyl alcohol (9:0.96:0.04 v/v/v respectively) to remove non-
nucleic acid cellular macromolecules from the sample thereby cleaning up the DNA 
extract. DNA was recovered from the sample by binding to silica in spin columns using 
the Zymo DNA Clean and Concentrator-5 Kit™ (Zymo Research, Irvine, CA) following 
manufacturer’s instructions. DNA bound to the spin columns was eluted using TE-4 (10 
mM Tris-Cl, pH 8.0 containing 0.1 mM EDTA).  
 
 DNA Quantification 
 DNA was quantified in extracts spectrophotometrically on a Nanodrop® ND1000 
(Thermo Fisher, Waltham, MA). Concentration and purity were determined using 







 Cytosine methylation occurs naturally throughout the genome of eukaryotic and 
prokaryotic organisms. A methyl group is added to the fifth carbon position of a 
guanine/cytosine site via endogenous methyltransferase activity. Characterization of 
methylation sites in genomic DNA provides insight into gene regulation that has 
implications in aging and disease. Frommer et al. showed that bisulfite treatment of DNA 
chemically modifies unmethylated cytosines resulting in their conversion to uracil 
(Frommer et al., 1992). Once the DNA is converted through bisulfite treatment, 
oligonucleotide primers can be designed to differentially amplify methylated or 
unmethylated CpG targets. Thus, it is rather straightforward to amplify genomic DNA 
that has been treated with bisulfite and assess potential methylation differences based 
upon which of the oligonucleotide primers mediate amplification of a product.  
 Twenty microliters containing approximately 1 µg of extracted DNA were 
subjected to bisulfite treatment using the EZ DNA Methylation-Lightening™ Kit 
(Invitrogen, Carlsbad, CA) to enable the differentiation of methylated and unmethylated 
CpG sites. The protocol provided with the kit was followed to convert unmethylated 
cytosines into uracil while methylated cytosines remained unchanged. Lightening™ 
Conversion Reagent containing 45% ammonium bisulfite was mixed with the DNA 
sample and conversion occurred in an Applied Biosystems 2700 Thermocycler (Life 
technologies, Carlsbad, CA) programmed to reach a temperature at which unmethylated 
cytosines become deaminated.  Thermocycler conditions consisted of 8 minutes at 98 ֯ C 
and 60 minutes at 54 ֯C. Bisulfite treated samples were mixed with M-Binding Buffer and 
centrifuged in an EZ DNA Methylation-Lightening™ Conversion column and washed 
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with M-Wash Buffer. Addition of L-Desulphonation Buffer converted all deaminated 
cytosines to uracil.  Two additional washes were performed, and the samples were eluted 
with DNase/RNase free water. Samples were stored at -20֯ C until testing. 
 
Primer Design for Methylation Study 
 Primers were designed to target identical loci in genomic DNA but differed 
biochemically in 2 ways (L. Zhang et al., 2012). The primers intended to target 
unmethylated cytosines terminated in A residues at GC sites and thus were 
complementary to the uracil residues converted from unmethylated cytosine. In this way, 
forward primers contained thymine and reverse primers contained adenine in the 
unmethylated cytosine positions.  Furthermore, amplified PCR product lengths differed in 
that amplicons produced from DNA containing methylated cytosines were between 15 
and 20 base pairs longer than amplicons produced from the same, but unmethylated 
target. This primer design allowed easy visual differentiation between methylated and 
unmethylated products using agarose gel electrophoresis of amplified products. Primers 
for methylated sequences were complimentary to available GenBank sequences. Primers 
sequences for methylated and unmethylated PER1, PER2, CRY1, CRY2, BMAL1, NPAS2 
and CLOCK were taken from a previously published study (L. Zhang et al., 2012). 
Methylated and unmethylated primers for PER3 were designed in house following the 
same strategy for primer design as discussed above. Primer sequence accuracy and 
specificity were determined using the Basic Local Alignment Search Tool (BLAST) for 
nucleotides on The National Center for Biotechnology Information (NCBI) site 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi). Primer self-complementarity and dimer 
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formation were assessed using the PrimerBlast tool 
(https://www.ncbi.nlm.nih.gov/tools/primer-blast/index.cgi) on the NCBI site. Primers 
were commercially produced by Invitrogen (Invitrogen, Carlsbad, CA). 
 
Table 1. Methylated and Unmethylated Primers. This table contains primer sequences, 
expected product sizes of each amplicon and the location of the amplified target in 












298 -1879 to -1860 





318 -1889 to -1860 





140 -178 to -159 





160 -188 to -159 





182 -453 to -444 





194 -465 to -444 





166 -420 to -401 





187 -432 to -401 







149 -308 to -289 





170 -318 to -289 





168 -454 to -433 





188 -467 to -433 





140 -84388 to -84366 





158 -84399 to -84365 





138 30 to 39 





161 18 to 39 
153 to 178 
Note: MForward: forward primer directed specifically toward methylated sequences; 
MReverse: reverse primer directed specifically toward methylated sequences; UForward: 
forward primer directed specifically toward unmethylated sequences; UReverse: reverse 
primer directed specifically toward unmethylated sequence. 
 
Methylation Controls: 
 CpG methylase attaches a methyl group to all cytosine residues in a DNA sample 
containing the dinucleotide sequence 5’ ….. CpG ….3’. One microgram of a control 
DNA sample (supplied with STR typing kits) was methylated with a CpG methylase 
isolated from Escherichia coli expressed Spiroplasma sp. strain MQ1 methyltransferase 
available commercially (Zymo Research, Irvine, CA). The methylated product was used 
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as a positive methylation control with all primer pairs. Methylated reactions consisted of 
a mix of CpG reaction Buffer, S-adenyosymethionine (SAM) acting as the methyl donor, 
CpG methylase, and extracted DNA. The methylase mix was incubated at 30 ֯C for 2 
hours. Negative controls were represented by non-bisulfite treated DNA.  
 
Polymerase Chain Reaction (PCR) for Methylation Study 
 Each PCR reaction consisted of 10 ng of DNA combined with 1 µl of a 1X primer 
mix (forward and reverse, 1 µM final concentration), and 5 µl GoTaq® Hot Start DNA 
Polymerase (Promega Corporation, Madison, WI) in a total volume of 10 µl. Positive and 
negative methylation controls were included in each reaction. Optimized PCR settings 
were determined for methylated and unmethylated reactions using temperature gradient 
conditions on an MJ Mini Personal Thermocycler (BioRad, Hercules, CA). Once optimal 
cycling conditions were determined, amplifications were routinely performed on an 
Applied Biosystems GeneAmp®PCR System 2700 Thermocycler (Applied Biosystems, 
Inc., Foster City, CA).  Final optimized cycling conditions varied in annealing 









Agarose Gel Electrophoresis 
 One microliter of loading dye was added to 5 µl of each amplification product and 
added to sample wells of a 2.5% agarose gel. A 100 bp DNA ladder (Thomas 
Laboratories, Swedesboro, NJ) was also electrophoresed with amplifications for size 
comparisons.  Agarose gel electrophoresis was performed in TAE buffer (.04M tris 
acetate, .001M EDTA, pH 8.3) and visualization of DNA fragments was made possible 
with GelRed® Nucleic Acid Stain (Thomas Laboratories, Swedesboro, NJ). Samples 
were separated at 500mA current. Syngene InGeniusL Syngene Bio Imaging System 
(Synoptics Ltd, Cambridge, England) was used to capture and save gel images. 
 
Temperature Time Number of 
cycles 
Primers used per specified 
annealing temperature 
95°C 2 minutes 1 cycle  
95°C 30 seconds 
30 cycles 
72°C 30 seconds 
55°C 
30 seconds 
UPER1, MPER1, MCRY1, 
UCLOCK, MCLOCK, MCRY1 
57°C 
UPER2, MPER2, UPER3, UPER3, 
UBMAL1 
59°C 






Donor Selection for Expression Studies 
 Donor selection guidelines were identical to those used in the methylation study.  
 Donors for the Stability Study: Three volunteers were randomly selected to 
participate in the stability study.  
 Donors for the Age Comparison Study: Donors were selected and categorized by 
age. Group 1 consisted of volunteers between the ages of 20 and 29 years old. Group 2 
involved volunteers that ranged in ages from 30 to 39 years old. Group 3 included 
volunteers between the ages of 40 to 49 years old and group 4 volunteers were between 
50 to 59 years old. A minimum of three male and three female volunteers from each age 
group were selected. 
  Donors for the 24-Hour Expression Pattern Study: Volunteers selected 
were screened for sleep patterns as discussed previously and additionally were required to 
be trained in blood collections and safety practices involved in biohazardous material 
handling as well as sharps safety. 
 
Blood Collection for Expression Study 
General Venipuncture Blood Collection: The experiments designed to assess the 
stability of mRNAs expressed by circadian rhythm genes required larger blood volume 
sample sizes to accommodate multiple RNA extractions from each blood stain stored in 
the lab over a period spanning 8-days. Venipunctures were performed by certified 
medical professionals to acquire 3-5 mL of peripheral blood. Venous blood samples were 
collected using 22-gauge needles fitted onto 5 cc anticoagulant-free syringes, and 
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immediately spotted on nuclease-free 705™Classic Specimen Cards (Fitzco®, Spring 
Park, MN). Collection dates and times were documented for each sample and specimen 
cards were stored in the dark at room temperature prior to extractions. 
General Fingerstick Blood Collection: Fingerstick samples for capillary blood 
were performed with SurgiLance™ 2.8 mm 21-gauge safety lancets (MediPurpose™, 
Duluth, GA) by a certified medical professional. Capillary samples were spotted in a 
20mm circumference onto nuclease-free 705™ Classic Specimen Cards (Fitzco®, Spring 
Park, MN). Specimen cards were stored in the dark at room temperature. The times and 
dates for both collection and extraction of blood stains were documented for each sample.  
Capillary blood was collected for the study of physiologic variability in gene 
expression among each blood donor via a fingerstick at approximately 1:00 pm +/- an 
hour for a minimum of 3 collections in the span of 3 weeks.  
Age Comparison Study: Forty capillary blood samples were collected via a 
fingerstick at approximately 1:00 pm +/- an hour from volunteers from different age 
groups.  
 24-Hour Expression Patterns Study: Each volunteer received a collection kit that 
consisted of 7 SurgiLance™ 2.8mm 21-gauge safety lancets (MediPurpose™, Duluth, 
GA) , 10 alcohol pads, 10 sterile gauze squares, and one nuclease-free 705™ Classic 
Specimen Cards (Fitzco®, Spring Park, MN). A biohazard bag was included to deposit 
used supplies for return and proper disposal. Instructions were included with each kit 
(Appendix D).  Capillary blood was collected via a fingerstick every 4 hours over a 24-
hour period. Sample collection began at 8:00 am and was completed by 4:00 am. 
Volunteers were instructed to allow the samples to air dry and to return the specimen 
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cards no later than 24 hours after the last sample was collected. Additionally, biohazard 
and sharps safety were discussed. Appropriate safety material was provided, and all used 
and unused material was returned for proper handling. Specimen cards were stored in the 
dark at room temperature for no more than 48 hours prior to extraction of total RNA from 
each sample. Collection time and RNA extraction times were documented for each 
sample. 
Venipuncture and fingerstick needle handling were in line with current sharps 
safety (OSHA regulation 29 CFR 1910.1030(d)(2)(i)) and disposal guidelines (OSHA 
requirements 29 CFR 1910.1030(d)(4)(iii)(A)(2)(i)). 
 
RNA Extractions for Expression Study 
 Stability Study: A portion of the dried blood sample specimen card was excised 
for extraction each day for 8 days. Day 0 was extracted within 2 hours of collection to 
allow the sample to completely dry prior to processing. All subsequent RNA extractions 
were performed within +/- 1 hour of the time at which the time zero extraction was 
performed. A 20 mm x 20 mm portion of the sample card was cut into 1-2 mm strips and 
placed into 2.0 ml microfuge tubes.  
 
General RNA Extraction Protocol  
 One milliliter of Trizol® (Sigma Aldrich, St Louis, MO) was added to the blood 
stain and the constituents were agitated at low speed on a Phenix Benchmix 1000 
(Thomas Laboratories, Swedesboro, NJ) for 30 minutes at room temperature. Following 
the 30-minute agitation, 200 µl of chloroform was added to the blood/Trizol mixture that 
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was inverted continuously by hand for 30 seconds. The microfuge tube was placed into a 
rack at room temperature for 3 minutes followed by centrifugation for 15 minutes at 
12,000 g at 4°C. After centrifugation, the aqueous (upper) layer containing the cell-free 
nucleic acids was transferred to a new 1.5 ml microfuge tube. The addition of 550 µl 
100% ethanol precipitated the nucleic acids. The ethanol mixture was transferred to a 
Zymo Spin Column seated in a reservoir and centrifuged for 30 seconds at 10,000 g. 
Total RNA was recovered from the extract using the Zymo RNA Clean and 
Concentration Kit™ (Zymo Research, Irvine, CA). The manufacturers protocol was 
followed for cleaning and purification of the sample. Nucleic acids were eluted using 15 
μl of DNase/RNase-free water.  
 
RNA Quantification  
 The Qubit RNA HS Assay Kit (Invitrogen, Carlsbad, CA) was utilized for RNA 
quantification. One microliter of undiluted nucleic acid eluate was mixed with 199 µl of 
Qubit™RNA HS Buffer and 1 µl Qubit™RNA HS Reagent 200X concentrate in a 
Axygen 0.5 ml tube. The use of the RNA HS reagents assures measurement or RNA with 
minimal interference of dsDNA and ssDNA. Tubes were briefly vortexed and RNA 
concentration was quantified using a Qubit™ Fluorimeter 2.0 (Invitrogen, Carlsbad, CA).  
 
DNase Treatment 
 All quantified RNA extracts underwent DNA digestion with the Invitrogen™ EZ 
DNase™ System (Invitrogen, Carlsbad, CA) per the manufacturer’s protocol to remove 
potential contaminating residual genomic DNA that might interfere with mRNA 
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quantitation assays. The entire RNA extract (~14µl remaining) was combined with 1.5 µl 
10X ezDNase™ buffer and 1µl ezDNase™ enzyme and placed in a 37°C water bath for 2 
minutes.  The sample was placed on ice immediately following incubation. 
 
Reverse Transcription  
 Reverse transcription with Invitrogen SuperScript IV™ VILO RT reverse 
transcriptase (Invitrogen, Carlsbad, CA) was performed following supplier protocols for 
all RNA extracts immediately following ezDNase™ treatment. The Superscript IV™ 
VILO master mix kit uses a combination of random and oligo dT primers for reverse 
transcriptase with a recombinant reverse transcriptase engineered to exhibit reduced 
RNase H activity and high processivity (Thermo Fisher, Waltham, MA). The entire RNA 
extract was transferred to a clean 0.2 ml PCR amplification tube and 4 µl of SuperScript 
IV™ VILO RT master (5X) mix was added. The reaction was placed in a MJ Mini 
Personal Thermocycler (BioRad, Hercules, CA) for 1 cycle of 25°C for 10 minutes, 50°C 
for 10 minutes and 85°C for 5 minutes. 
 
Primer Design for Expression Study 
Stability Study – Primer Design 
 PERIOD 1, PERIOD 2, PERIOD 3, CRYPTOCHROME 1, CRYPTOCHROME 2 
and CLOCK genes that were discussed in Chapter 2 were selected for this study. 
Publications of previous research involving these markers served as a guide for target 
locations for qPCR amplification within the mRNA and for primer selection (Liu et al., 
2007; Yang et al., 2006).  S100A12-241 primers were designed and supplied by the 
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Forensic DNA lab of Dr. Robert W. Allen (Fu and Allen 2019) The S100A12 mRNA 
transcript is expressed at constant levels in blood and was quantified to normalize qPCR 
results obtained for the circadian rhythm markers. The S100A12 protein belongs to a 
superfamily of Ca2+ binding proteins. S100A12 protein is released by neutrophils (Vogl et 
al., 1999) and is involved in a proinflammatory pathway that facilitates leukocyte rolling 
and extravasation (Foell et al., 2013).  The 241 region of the S100A12 mRNA lies within 
a coding region of the transcript distant from the 3’ end of the transcript and exhibits 
stability in dried blood stains (Fu & Allen, 2019). The abundance of the S100A12-241 
mRNA fragments in dried blood stains produced Cq values during qPCR in the 18 to 20 
range that was deemed appropriate for normalization of clock mRNA levels whose Cq 
values ranged from 27 to 32 depending upon the particular sample. Amplicon target 
lengths between 100 and 150 base pairs were favored for qPCR targets and amplicons 
with similar lengths allowed for possible later applications in PCR multiplexing. 
 Primer location is a critical consideration for primer design. The environment in 
which a forensic sample is recovered from a crime scene can promote degradation of 
biomolecules contained within a stain and thus, in the case of mRNA, the region to be 
amplified must be located within a stable area in order to avoid degradation issues and 
yield accurate transcript quantity estimates. Previous research concerning selected mRNA 
(PER1, PER2, PER3, CRY1, CRY2, CLOCK) were referenced to aid in the strategy 
regions targeted for amplification (Liu et al., 2007; Yang et al., 2006). Primers were 
designed to reduce primer dimers and self-complementarity and to contain approximately 
50% guanine/cytosine residues. A melting point target for the primers of 55-60֯ C allowed 
optimization of primer sets for each target to facilitate planned multiplexing. Primer 
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specificity to the targeted area of interest was evaluated using Basic Local Alignment 
Search Tool (BLAST) for nucleotides on The National Center for Biotechnology 
Information (NCBI) site (https://blast.ncbi.nlm.nih.gov/Blast.cgi). Primer self-
complementarity and dimer formation was assessed using the PrimerBlast tool 
(https://www.ncbi.nlm.nih.gov/tools/primer-blast/index.cgi) on the NCBI site. 
Characteristics of the primers designed are shown in Table 3 below. 
 
Table 3. Primer Characteristics for Expression Study. 
Primer Primer Sequence Tm Product Length 
PER1 F 
PER1 R 
5’ GAATACTACCAGCAGTGGAG 3’ 






5’ GAAATCCGCTACCACCCCT 3’ 






5’ GAGACGCAATAAACCAAGCA 3’ 






5’ TCCAAGGCCTGGATGCTAATC 3’ 








 In an extension of our studies on the stability of RNA transcripts in dried stains, 
PCR primers were designed to amplify larger segments of a handful of circadian rhythm 
transcripts, the notion being that successful amplification of longer pieces of each 
transcript would confirm the degree of intactness of the mRNA in dried stains. In order to 
assess that minimal degradation existed in the mRNA, additional primers flanking the 
CLOCK, PER3 and TPOH genes were designed. Since these primers were designed to 
amplify longer fragments and are not intended to be used in later applications in 
multiplexing, melting temperature and fragment length were not restrictive. 
 
Table 4. Primers for Larger Products to Refute Degradation. Primers designed to 5’ 
and 3‘ flanking regions of initial primer sets for PER3 and TPOH. Intact mRNA was 
assessed with combinations of the new long(L) primers and the original primer sets from 






























LCLOCK F 5’ CCAACCCCTTCTGCCTCTTC 3’ 64° 671-692  1411 bp  730 bp 
LCLOCK R 5’ AAATGCTGCCTGGCTGGAG 3’ 60° 2091-2111   800 bp  
LPER3 F 5’ TGTTGGAGGGAAAAGCTCCT 3’ 60° 82-100  1436 bp  504 bp 
LPER3 R 5’ ACGTGAACTGGCTGTAAGAGA 3’ 62° 1497-1517   1047 bp  
LTPOH F 5’ ACCATTGTGCCAACAGAGTTC 3’ 62° 402-423  1403 bp  663 bp 




Physiologic Variation Study - Primer Design 
 The purpose of this study was to analyze the biological variability in the 
quantities of mRNA transcripts for rhythmicity expressed genes among our pool of blood 
donors consisting of unrelated males and unrelated females. Primers targeting core clock 
gene cDNA, as described previously in the Stability Study, were used. Primers for 
markers targeting additional clock genes and supplementary rhythmic genes were added 
for this study. The addition of gene markers beyond the core clock genes provided 
increased sensitivity to detect additional, time-dependent patterns of gene expression.  
 In order to develop an assay for estimating the time of day a stain was created, it 
is imperative that a reference pattern of gene expression exhibiting peaks and troughs 
over the course of a 24-hour period be available to estimate the deposition time for an 
unknown. With multiple gene markers exhibiting varying patterns of gene expression, 
time determination should be more accurately estimated within a narrow window of time 
associated with a crime. The additional rhythmic genes selected have been reported to 
exhibit oscillating patterns of expression in various peripheral tissues (Ebert-Zavos, 
Horvat-Gordon, Taylor, & Bartell, 2013; Lech et al., 2015; Masri, Cervantes, & Sassone-
Corsi, 2013). Publications of previous research using the genes of interest were reviewed 
(Champier et al., 1997; Kusanagi et al., 2008; Lech et al., 2015; Salani et al., 2007) and 
primer sequences and target positions within each transcript were considered for this 
study. Primer sequences generally targeted a central position in the mRNA sequence and 
we have confirmed for many transcripts that this area of the mRNA is the most resistant 
to degradation (Fu & Allen, 2019). Primers were synthesized to direct amplification of 
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BMAL1 from the core clock mechanism and CYE, MKNK, THRA1, and TPOH from the 
secondary line of circadian rhythm. Table 5. 
 
Table 5. Additional Primers for Expression Study. 




5’ CCCATTGAACATCACGAGTAC 3’ 






5’ CCAACCCCTTCTGCCTCTT 3’ 






5’ TTGGAAAGGAACGAGACGC 3’ 






5’ GTGTGGAAGTAGTGACGGA 3’ 






5’ GTTGCACCAGTTTGCGTATG 3’ 






5’ CATAACAAAGGCATCGCCC 3’ 




THRA1 F 5’ GTGTGGGGACAAGGCAAC 3’ 58°C 120 bp 
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THRA1 R 5’ CTGTCATATTTGCAGGAATAG 3’ 56°C 
TPOH F 
TPOH R 
5’ GCTGTTCAAAAACTGGCAAC 3’ 





 Primers were designed to reduce primer dimers and self-complementarity and to 
contain approximately 50% guanine/cytosine residues. A melting point target for the 
primers of 55-62֯ C allowed for optimized activities of both primer sets and later 
applications. Primer sequence accuracy and specificity to amplify only the target of 
interest was evaluated using the Basic Local Alignment Search Tool (BLAST) for 
nucleotides on The National Center for Biotechnology Information (NCBI) site 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi). Primer self-complementarity and dimer 
formation was determine using the PrimerBlast tool 
(https://www.ncbi.nlm.nih.gov/tools/primer-blast/index.cgi) on the NCBI site. Melting 
curves for each primer set were performed to verify that only one amplified product 
would be produced. Efficiency tests for select primers provided evidence that 
amplifications were at optimal capacity and shared similar efficiencies. This assured that 
variations in amplification quantities reflected mRNA amounts and eliminated variations 








Polymerase Chain Reaction (PCR)  
Stability Study PCR  
 PCR reactions for longer amplicons contained 10 ng of cDNA from Sample 2, 
day 0 and Sample 2, day 2 from the stability study described above. Additionally, 5 µl 
GoTaq® Hot Start DNA Polymerase (Promega Corporation, Madison, WI) and 1 µl of a 
1X (10 µM final concentration) of primer mix ((Long forward(LF)/Long Reverse(LR) 
F/LR, F/R and LF/R as described in Table 2) was added for a 10 µl final volume. 
Amplification was performed on a GeneAmp® PCR System 2700 (Life Technologies, 
Carlsbad, CA) as described in Table 6.  
 













Quantitative PCR (qPCR) 
 Quantitative PCR was used to quantify mRNA levels in blood stains stored for 
varying periods to assess RNA degradation in a stored sample. All qPCR reactions were 
analyzed in MicroAmp®Fast 96-well reaction plates (0.1 mL) (Life Technologies, 
Carlsbad, CA).  Each reaction consisted of 10 ng of cDNA with nuclease free water to a 
total of 4 µl and 1 µL of an 8 µM forward and reverse primer mix (final primer 
concentration was 0.8 µM) . Five microliters of PowerUp™SYBR™Green Master Mix 
(Life Technologies, Carlsbad, CA) was added to the cDNA/primer mix to a total 10 µL 
volume reaction. All reactions were performed in triplicate to distinguish preparational, 
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technical and random errors. Each reaction plate was analyzed on a 7500 Real Time PCR 
System (Life Technologies, Carlsbad, CA). qPCR reaction conditions are listed in Table 
7. 
 
Table 7. Quantitative PCR Conditions. 
Denaturation Amplification – 40 cycles Disassociation 
50°C 95°C 95°C 58°C 72°C 95°C 60°C 
2 min. 2 min. 15sec. 15 sec. 1 min. 15 sec. 1 min. 
 
Disassociation curves for each primer set were performed to verify that only one 
amplified product was produced, and thus that data acquired from amplification 
accurately reflected quantities of the targeted mRNA. Efficiency tests for primers 
demonstrated that all primers were optimally efficient, that each primer set shared similar 
efficiencies and that cDNA preparations did not contain endogenous or exogenous 
inhibitors. 
 
Agarose Gel Electrophoresis for Stability Study  
 Agarose gel electrophoresis was performed to visualize PCR amplicons from long 
primer sets directing amplification of long amplicon products. One microliter of loading 
dye was added to 5 ul aliquots of each amplified product and then added to sample wells 
of a 2.5 % agarose gel containing Phenix GelRed®Nucleic Acid Stain (Thomas 
Laboratories, Swedesboro, NJ). A 100 bp reference ladder was included in the gel for 
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size determination. TAE buffer (0.4M tris acetate, 0.01M EDTA, pH 8.3) was the 
running buffer for electrophoresis using 500 mA current. Gel images were captured with 
a Syngene InGeniusL Bio Imaging System (Synoptics Ltd, Cambridge, England). 
Agarose gels were assessed for expected length amplicons in order to verify that mRNA 
was intact in the samples tested. 
 
Data Analysis General 
 Results from qPCR analysis were performed using 7500 Applied Biosystems 
Software version 1.2.3. A quantification cycle (Cq) reflects the point in amplification 
when the product signal crosses the threshold and higher Cq results indicate lower 
concentrations of mRNA. Instrument default settings were used to establish threshold 
values. Cq levels of each triplicate assay were averaged and standard deviation values 
greater than 0.5 were reviewed for stochastic events. Normalization of qPCR results is 
important in order to reduce experimentally induced variation. Therefore, Cq values of 
S100A12 or CLOCK were subtracted from each transcript Cq for accurate quantitative 
levels or expression. 
 
Stability Study Data Analysis 
 All Cq data produced for each marker quantified with qPCR in RNA extracts 
produced from stains stored for the different time points (incorporating data from 24 
samples) were combined and plotted as a line graph using Microsoft® Office Excel (US 
Microsoft Corporation, Redmond, WA). A one-way ANOVA was used to determine if 
the time elapsed from sample collection to the time the RNA was extracted differed 
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significantly in terms of Cq values. Cq values for transcripts extracted from stains stored 
for varying periods that did not differ significantly from freshly prepared stains were 
accepted to reflect intact mRNA with minimal degradation. Results produced using qPCR 
were supported by results produced using agarose gel electrophoresis demonstrating the 
presence of larger PCR products amplified from RNA extracts stored for the short 
periods elapsing from blood collection to RNA extraction. 
 
Physiologic Variation Study Data Analysis 
  Samples were normalized to S100A12 and CLOCK. Normalized Cq values for 
triplicate qPCR reactions for each volunteer and for each primer set were averaged. 
Coefficient of variation (CV) results were calculated using Microsoft® Office Excel to 
determine the normal amount of variation that can be expected within an individual 
whose blood was collected at the same time on different days. Data from this study 
defined experimental variation in terms of the individual markers among biological 
replicates of RNA extracts from a single individual and ultimately these experiments 
allowed for the identification of circadian rhythm markers that exhibit a narrow range of 
gene expression over a 24-hour period. A narrow range of variation in gene expression is 
preferred for establishing reference patterns of rhythmic gene expression to be used 
forensically.  
 
Age Comparison Study Data Analysis 
  Another possible source of variation in qPCR results relates to the age of the 
blood stain sample donor. The abundance of gene transcripts in stains created for each 
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age group were normalized to expression levels of S100A12 and CLOCK. Mean values, 
standard deviations and standard errors were calculated using Microsoft® Office Excel.  
A one-way Anova, with a post hoc Tukey Test with Prism 8™ GraphPad (GraphPad 
Software, San Diego, CA), was used to determine if there was a significant difference in 
the expression of circadian genes between age groups (20’s vs 30’s, 30’s vs 40’s, etc). 
Subsequently, data from men and women were separated to determine if there was a 
significant sex-related difference in donor age groups. The same statistical approach was 
used to determine if there was a significant difference between men and women 
regardless of age. 
 
24-Hour Expression Pattern Study Data Analysis 
 Triplicate qPCR values for each time point were averaged and normalized to 
CLOCK and S100A12 levels. Male and female data was separated prior to further data 
analysis. Data from each time point was combined and mean values, standard deviations 
and standard errors were calculated using Microsoft® Office Excel.  Combined data for 
each time point is shown as a line graph representing mean values with standard errors 
for every 4-hour time point over a 24-hour day. Each marker was assessed in this way. 
Graphs for male and female data were displayed separately. The most reliable markers 
for time determination were considered those that exhibited rhythmic patterns that 









Optimization of Methylated and Unmethylated Primer Sets 
 In order to accurately quantify DNA through PCR amplification it is imperative 
that reaction conditions are optimized for each set of primers. In this way, varying levels 
of amplicon products observed after amplification accurately reflect their physiologic 
levels. This was the rationale for experiments aimed at optimizing PCR conditions to 
detect the relative proportions of methylated and unmethylated DNA associated with 
genes whose expression is linked to the circadian rhythm. The DNA sample used in these 
experiments was the same in order to provide accurate comparisons and more accurately 
identify optimal amplification conditions. Experimental amplification cycles were 
performed with each primer set and amplification products were electrophoresed on 
agarose gel for visual comparisons and relative quantification. The preferred PCR 
conditions were those that exhibited the brightest targeted bands that unique to 
amplifications directed by specific pairs of primers (i.e. were not non-specific 
amplification products). The principal variable evaluated in this study was the annealing 
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temperature whose effect manifested itself in the intensity of the amplicon band in the 
agarose gel and allowed the most effective amplifications conditions to be determined. 
Annealing temperatures ranged from 55°C to 61°C with all other conditions unchanged. 
 Effective amplification of genomic DNA with primers specific for methylated 
CpG sites required methylation positive DNA and thus methylation of random DNA was 
performed for a 2-hour period as described in the CpG Methylase protocol (Zymo 
Research, Irvine, CA). These methylated DNA samples were bisulfite treated (bisulfite 
treatment was performed to include each step that would be used for random samples) 
with subsequent amplification with methylated primer sets. Bisulfite treated random 
DNA was also used to program amplification using the unmethylated primer sets. 
Gradient temperature increases for the PCR reactions were performed in a MJ Mini 
Personal Thermocycler (BioRad, Hercules, CA). Five microliters of the PCR products 
were separated by agarose gel electrophoresis and the intensities of amplicon bands were 
evaluated. Images of the gel can be seen in Figures 4 and 5. Tables 8 and 9 provide the 
details about the amplicons in each well, their expected size and the temperature of each 






Figure 4. Conditions for Methylation Primers PER1-3 and CRY1. Bands ranging 
from 140 bp to 318 bp represent specific target amplicons. Bands below 100 bp represent 
excess primers and primer dimers. Lane 1 and 14 contain 100 base pair ladders. Table 8 
describes the lane specifics for each reaction.  
 
  
1     2     3     4    5     6    7    8     9    10   11  12  13  14  
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Table 8. Conditions for Methylation Primers PER1-3 and CRY1. The table reflects 
the contents of each lane of the gel in figure 4, the expected band sizes of each amplicon 
and the annealing temperatures used in each reaction. Interpretations of the products have 
been noted in the comments section of the chart and the temperature selected for 
subsequent experiments are indicated with an asterisk ”*”. 





1 100 bp ladder    
2 PER1 methylated 289 bp 55°C Acceptable * 
3 PER1 unmethylated 318 bp 55°C Acceptable * 
4 PER2 methylated 140 bp 57°C Acceptable * 
5 PER2 unmethylated 160 bp 57°C Acceptable * 
6 PER3 methylated 182 bp 57°C Acceptable * 
7 PER3 unmethylated 207 bp 57°C Acceptable * 
8 CRY1 methylated 166 bp 55°C Acceptable * 
9 “      “       “        “ “    “ 57°C Acceptable 
10 CRY1 unmethylated 187 bp 55°C Non-specific 
band 
11 “      “       “        “ “    “ 57°C Non-specific 
band 
12 “      “       “        “ “    “ 59°C Acceptable * 
13 “      “       “        “ “    “ 61°C Acceptable 







Figure 5. Conditions for Methylation Primers CRY2, CLOCK, BMAL and NPAS2). 
Optimization of annealing temperature for primers directing amplification of methylated 
and unmethylated genes (CRY2, CLOCK, BMAL1, and NPAS2) Amplicons produced 
with varying annealing temperature. Lanes 1 and 10 are 100 bp ladders. Details of each 
reaction is described in Table 9.  
 
  





Table 9. Conditions for Methylation Primers CRY2, CLOCK, BMAL1 and NPAS2. 
Expected sizes of amplicons and annealing temperatures for each reaction are included 
within this table. Interpretations of the PCR products have been noted in the comments 
section of the chart. An asterisk ”*”indicates the temperature selected for subsequent 
PCR reactions with each specific primer set.  





1 100 bp ladder    
2 CRY2 methylated 149 bp 55°C Acceptable * 
3 “      “       “        “ “    “ 57°C Weaker 
4 CRY2 unmethylated 170 bp 55°C Acceptable * 
5 “      “       “        “ “    “ 57°C Acceptable 
6 “      “       “        “ “    “ 59°C Acceptable 
7 “      “       “        “ “    “ 61°C Acceptable 
8 CLOCK methylated 168 bp 55°C Acceptable * 
9 CLOCK unmethylated 188 bp 55°C Acceptable * 
10 100 bp ladder    
11 BMAL1 methylated 138 bp 57°C Weaker 
12 “      “       “        “ “    “ 59°C Acceptable * 
13 BMAL1 unmethylated 161 bp 57°C Acceptable * 
14 NPAS2 methylated 140 bp 59°C Acceptable * 
15 “      “       “        “ “    “ 61°C Acceptable 
16 NPAS2 unmethylated 158 bp 59°C Acceptable * 
17 “      “       “        “ “    “ 61°C Acceptable 
 
 Band intensity was used to determine the optimal amplification conditions with 
each primer set. In some cases, one temperature was used to verify the conditions used in 
the publications from which the primer sequences were derived. Based on the gradient 
annealing experiments from above, a 55°C annealing temperature for primers, PER1 
M(methylated), U(unmethylated); CRY1 M; CRY2 M, U; and CLOCK M, U was 
selected for all future experiments. An annealing temperature of 57°C was selected for 
PCR reactions using PER2 M, U; PER3 M, U; and BMAL1 U primer sets while 59°C 





CpG Methylase Verification 
 Amplicon bands produced with primers targeting methylated DNA appeared 
weaker than products amplified from unmethylated DNA. The CpG Methylase Protocol 
(Zymo Research, Irvine, CA) states an incubation time of 2 hours for methylation but 
allows up to 24 hours for complete methylation to occur. A new sample of DNA was 
methylated with the CpG Methylase Reagents (Zymo Research, Irvine, CA) but to 
optimize methylase activity, a 24-hour incubation time was used. It is likely that weaker 
bands in the previous protocol were due to lesser amounts of methylated products. Thus, 
an annealing temperature of 55°C was used with primers for methylated PER1, CLOCK, 
CRY1, and CRY2. Primers for methylated PER2 and PER3 had annealing temperatures 
of 57°C while methylated primer sets for BMAL1 and NPAS2 were exposed to annealing 
temperature of 59°C. The amplicon products were separated and visualized on an agarose 
gel (Figure 5). Results indicate an improved amplicon quantity with DNA template that 
was incubated for 24 hours in the methylase protocol. Additionally, PCR conditions used 







Figure 6. Methylation Amplicons from Methylase Treated DNA. Amplicon products 
using methylation specific primer sets with random DNA that was CpG Methylase 
treated over a 24-hour period. Lane 1 contains a 100 bp ladder. Lane 2 PER1M (289 bp), 
lane 3 PER2M (140 bp), lane 4 PER3M (182 bp), lane 5 CRY1M (166 bp), lane 6 
CRY2M (149 bp), lane 7 CLOCKM (168 bp), lane 8 BMAL1M (138 bp) and lane 9 
NPAS2M (140 bp). All results were produced using a single sample of genomic DNA (a 
positive control DNA supplied as part of an STR typing kit. 
 
24-Hour Methylation Pattern Assessment  
 Detectable methylation has been described previously (Parle-Mcdermott & 
Harrison, 2011) and epigenetic modifications have been identified in circadian rhythm 
machinery (Sahar & Sassone-Corsi, 2013) . Characterization of an identifiable and 
predictable methylation pattern in dried blood stains provides the opportunity to identify 
a timeframe during the biologic 24-hour day in which the stain was created and possibly 
associated with a crime. The optimized PCR conditions described in the previous 
paragraphs were applied to investigate the involvement of DNA methylation in the 
circadian expression of selected genes. Twenty-four capillary blood samples were 






collected from 3 volunteers every 4 hours for 24 hours.  DNA was extracted from the 
samples within 48 hours of collection. All DNA samples were bisulfite treated in order to 
convert any unmethylated CpG sites to uracil.  Those CpG sites that were methylated 
remained unchanged by bisulfite treatment. Aliquots of DNA from the donors was 
amplified with optimized conditions specific to each primer set. PCR products were 
electrophoretically separated in an agarose gel and band intensity was visualized (Figures 
7 – 12). 
 
Figure 7. Methylation Assessment of the PERIOD 1 Gene over 24-Hours. Lanes 1 
positive control, Lane 2 negative control. All time references are in relation to midnight. 
Zero hour refers to midnight while 4hr refers to 4 hours after midnight or 4:00 am. 
Samples amplified with primers for methylated sites are designated M while those 
amplified with primers for unmethylated sites are labeled with U. The expected size for 









Figure 8. Methylation Assessment of the PERIOD 2 Gene over 24-Hours. Methylated 
PERIOD 2 (PER2) amplicon expected length is 140 bp while unmethylated PER2 
amplicons are 160 bp. One hundred base pair ladders are in lanes 1 and 15. The time is 










Per2 M – 140bp     Per2 U – 160bp 
 









Figure 9.  Methylation Assessment of the PERIOD 3 Gene over 24-Hours. Lane 1 
contains a 100 base pair ladder. The expected length of amplicons from the methylated 
(M) primer set is 182 bp while the unmethylated primer set should have products of 207 
bp in length. Military time is applied to time references (i.e. 4hr = 4:00 am).  
  
Per3 M – 182bp     Per3 U – 207bp 







Figure 10.  Methylation Assessment of the CLOCK Gene over 24-Hours. Lane 1 
contains a 100 bp ladder. Methylated primer products should be 168 bp in length while 
unmethylated primer products are 188 bp. Time is based on military time (i.e. 8hr = 8:00 
am). 
  
CLOCK M – 168bp     CLOCK U – 188bp 
200 bp 







Figure 11. Methylation Assessment of the BMAL1 Gene Over 24-Hours. Lane 1 
contains the 100 bp ladder. The expected length of methylated (M) amplicons is 138 bp 
while the unmethylated amplicons should be 161 bp. Time points are expressed in 
military time (i.e. 12hr = 12:00 pm). 
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Figure 12.  Methylation Assessment of the NPAS2 Gene over 24-Hours. Lane 1 
contains the 100 bp ladder for size comparison. The expected product size of a PCR 
reaction using the methylated set of primers for NPAS2 is 140 bp while the unmethylated 
primer set is expected to produce a product of 158 bp in length. Time designations are 
based on military time (i.e. 16hr = 4:00 pm).  
 
The gel images were prepared using DNA extracted from blood from one of three 
volunteers used in this initial study. However, results shown for individual donors were 
reflective of results from all individuals who provided blood samples for the study. 
Amplicons of expected length were visualized at all time points in all reactions that 
targeted unmethylated target sequences. Extracted DNA from blood samples using 
methylated primer sets for PER1-2, CRY1-2, BMAL1, CLOCK, and NPAS2 yielded no 
visible amplification at any of the time points tested whereas positive controls exhibited  
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bands of methylated genes contained no products with the exception of the PERIOD 3 
gene which showed very weak bands in all time points. Fragment sizes for all amplified 
products were consistent with products of expected size. There were no non-specific 
bands present in any of the observed PCR reactions beyond residual primers and primer 
dimers below the 100 bp marker. 
 
Conclusion 
 Detection and correlation of epigenetic modifications of the genes involved with 
the circadian rhythm has gained momentum in the past decade. Applications of 
microarray technology provides evidence that rhythmic daily methylation patterns exist. 
In one such experiment, regions of DNA methylation in whole blood were reported with 
possible applications for the detection of senescence (Bell et al., 2012). Similarly, Day et 
al. evaluated methylated DNA among various tissues to correlate methylation and age, 
also using microarray technology (Day et al., 2013). Methylation of specific genes has 
also been investigated for forensic applications where Freire-Aradas et al. (2016) used 
microarray technology to correlate the age of an individual with the extent of the 
methylated DNA (Freire-Aradas et al., 2016).  Microarray technology yields evidence of 
rhythmic methylation but fails to pinpoint the specific genes involved. Correlation of 
DNA methylation with specific genes and implications with circadian rhythm will require 
a complex molecular understanding of genomics.  It is reasonable to assume that if 
methylation changes are associated with a 24-hour cyclic pattern, these chemical 
modifications may be involved with circadian rhythm. Joska et al. reported detection of 
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DNA methylation patterns involving circadian rhythm in Neurospora, mice and cancer 
cells (Joska, Zaman, & Belden, 2014).  
 In this study, methylation patterns were assessed over a 24-hour period to detect 
changes in genes that drive circadian rhythm. Primers specific to methylated or 
unmethylated sequences were used to determine if there are discernible methylation 
differences at multiple time points of the day.  This study revealed that all clock genes 
analyzed, at the targeted sights, remained unmethylated in every sample tested. 
Additionally, there was evidence that PERIOD 3 remained weakly methylated in every 
sample, continuously throughout the day. The atypical presentation of PERIOD 3 that 
differs from PERIOD 1 and PERIOD 2 may be explained in work reported by Shearman 
et al. where a Period 3 knockout mouse retained its rhythmicity while a knockout of 
Period 1 or Period 2 exhibited disrupted day/night cycles(Shearman, Jin, Lee, Reppert, & 
Weaver, 2000). The information gleaned from this finding suggests that although 
PERIOD 3 show interactions with core clock genes, it may not be necessary to drive the 
circadian rhythm. Theories exist that PERIOD 1 and PERIOD 2 represent redundant 
drivers of rhythmicity in case one gene is lost. Additional functions of PERIOD 3 are 
currently under investigation. Given the information gained from this experiment, 
differential rhythmic methylation patterns cannot be used to determine the time of day 
using this methodology and the markers selected. 
 It should also be noted that the tissue used in this study (i.e. blood stains) 
represents a complex mixture of different cell types and it is possible that rhythmic 
methylation of the genes studied here actually exist in some differentiated cell types but 
that the differential methylation patterns are obscured by the other cell types present. 
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Future experiments might be warranted in which blood cell subpopulations are separated 






mRNA STABILITY STUDY 
 
 
Results and Discussion  
 In experiments that aim to accurately quantify levels of gene expression during 
the daily cycle in dried blood stains, it is crucial to assure that the amount of mRNA 
detected at a particular time point represents the physiologic amounts in the donor. RNA 
degradation must be avoided as Fu and Allen (2019) correlated degradation in dried 
blood stains over time. Degradation of mRNA that might occur can falsely suggest 
decreased expression levels and confuse the interpretation of data. Since blood stains 
used in this study could be collected on one day and not subjected to RNA extraction for 
24-48 hours, because of weekends and other interfering circumstances, we assessed the 
effect of storage for short periods on the stability of the rhythm markers in dried blood 
stains. Dried blood stains were prepared from 3 volunteers and stored for up to 8 days in 
the laboratory before extraction and reverse transcription of total RNA. Extractions were 
performed immediately after spotting and drying of blood stains and every 24 hours for 8 
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days in the laboratory before extraction and reverse transcription of total RNA. 
Extractions were performed immediately after spotting and drying of blood stains and 
every 24 hours for 8 days. The specified clock gene markers PER 1-3 were quantified via 
qPCR. Raw data and normalized results produced from each time point were compared to 
results from Day 0 stain to determine if a significant difference in the quantity of each 
targeted mRNA from each storage time point. Genes of different expression levels were 
selected to account for possible accelerated degradation with low mRNA levels and to 
improve the sensitivity of the assay. 
 The Cq values for all markers were analyzed in triplicate and the raw data 
averaged. The mean Cq values of PER1-3 from each day were also normalized to the 
corresponding S100A12 Cq values. The S100A12 transcript was previously shown to be 
stable for the 8-day maximum storage period in this study (Fu & Allen, 2019). Data from 
each volunteer was reviewed individually. Additionally, Cq values from all volunteer 
samples were averaged from the raw and normalized data. Table 9. 
 
Table 10. Stability Results for PER1-3 Raw Data and Normalized to S100A12. 
Average of triplicate Cq values for PER1-3 and S100A12. Raw data represents the 
average of the triplicate run of each marker for each of 3 volunteers over 8 days. Each 
day is represented by a mean value for PERIOD 1-3 and an S100A12 mean values. 
Normalized values were obtained by subtracting the mean S100A12 value from the 























PER1 PER1 PER1 
  
0day 31.7 12.61 33.20 12.57 30.0 9.81 
       
1day 31.1 10.54 34.14 12.5 29.8 9.55 
2day 31.5 12.03 33.94 12.3 30.0 9.64 
3day 31.0 11.57 31.28 10.3 30.0 10.10 
4day 33.7 14.20 34.66 12.4 30.5 9.88 
5day 32.4 12.58 31.74 10.9 30.5 10.26 
6day 34.2 13.46 32.82 12.0 31.4 10.85 
8day 33.6 13.48 33.50 12.2 33.6 12.23 
  
PER2 PER2 PER2 
0day 29.4 10.24 31.2 10.60 28.7 8.56 
1day 31.1 10.54 31.9 10.27 28.6 8.29 
2day 28.9 9.47 31.2 9.63 28.8 8.51 
3day 27.6 8.17 28.2 7.29 28.6 8.70 
4day 28.0 8.51 29.6 7.34 29.5 8.81 
5day 29.3 9.49 29.7 8.88 29.1 8.92 
6day 31.3 10.57 30.0 9.20 30.1 9.52 
8day 29.7 9.56 30.0 8.72 32.1 10.70 
  
PER3 PER3 PER3 
0day 31.4 12.3 33.0 12.4 31.3 11.1 
1day 33.4 12.8 33.9 12.3 31.2 10.9 
2day 31.5 12.0 33.5 11.9 31.5 11.2 
3day 31.1 11.7 32.6 11.6 31.4 11.5 
4day 33.1 13.6 34.2 11.9 32.2 11.5 
5day 31.7 11.9 32.2 11.5 31.8 11.6 
6day 33.7 13.0 32.5 11.7 32.5 12.0 
8day 31.8 11.6 32.9 11.6 35.3 14.0 
  
S100A12 S100A12 S100A12 
0day 19.1 20.6 20.2 
1day 20.6 21.6 20.3 
2day 19.5 21.6 20.3 
3day 19.4 21.0 19.9 
4day 19.5 22.3 20.7 
5day 19.8 20.8 20.2 
6day 20.7 20.8 20.6 




 All raw Cq values were compared to day zero to determine if a significant 
difference existed during the 8-day extraction period (Figures 13-15). Subsequently, Cq 
values for PERIOD 1-3 were normalized to S100A12 and evaluated for evidence of 
degradation (Figures 16-18). 
 
Figure 13. PERIOD 1 Stability Raw Data. PERIOD 1 Cq data of three samples tested 
for degradation. Extractions of mRNA were performed over 8 days and qPCR assays 
performed. Quantitation of mRNA, expressed as Cq values, was observed and compared 
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Figure 14. PERIOD 2 Stability Raw Data. PERIOD 2 Cq data of the three samples 
tested. Extractions of mRNA were performed over 8 days and qPCR assays performed. 
Quantitation of mRNA, expressed as Cq values, was observed and compared to Day 0. 
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Figure 15. PERIOD 3 Stability Raw Data. Cq data of the three samples evaluated for 
degradation. Extractions of mRNA were performed over 8 days and qPCR assays 
performed. Quantitation of mRNA, expressed as Cq values, was observed and compared 
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Figure 16. PERIOD 1 Stability Data Normalized to S100A12. PERIOD 1 Cq values 
normalized to S100A12. Blood samples of 3 donors that were extracted over an 8-day 
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Figure 17. PERIOD 2 Stability Data Normalized to S100A12. PERIOD 2 Cq values 
normalized to S100A12 over an 8-day extraction period. Quantitative PCR Cq levels were 
normalized to corresponding S100A12 Cq levels for 8 consecutive days. Each normalized 
Cq value is plotted for the appropriate extraction day. The error bars represent the 
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Figure 18.  PERIOD 3 Stability Data Normalized to S100A12. PERIOD 3 Cq values 
normalized with corresponding S100A12 results. PERIOD 3 qPCR results (Cq) for an 8-
day period were compared to day 0 for degradation determination. The error bars 
represent the standard deviation for each time point. 
  
 The variability in mRNA abundance among individual sample donors and the 
combined average abundance for all three donors at each time point was unexpected. 
Combining male and female results could be one reason for the variability in individual 
versus combined data. Later experiments showed that differences may exist between 
sexes. Although sample collection at differing times during the day may result in variable 
levels, data was normalized and all samples averaged together. Combining data in this 
way should allow detection of shifts from day 0 as an overall trend. Instrument sensitivity 
may also be a contributing factor as Cq levels greater than 30 represent very low levels of 
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PER3 ranged from 31 to 35. Cq levels above 30 introduce the potential for a larger range 
in variability. It is possible that higher Cq values introduced some random error at 
different time points that muted the data when averaged.  
 Quantitative PCR results support the belief that little mRNA degradation occurs 
(at least for the 100 to 150 bp qPCR amplicons quantified) between when a sample is 
collected, and RNA is extracted and converted to cDNA. However, in an effort to more 
completely understand any degradative processes existing in dried blood stains, primers 
were designed to target flanking regions of the initial CLOCK, PERIOD 3 and TPOH 
targets that would direct the amplification of larger segments of each cDNA. The 
rationale of this approach was that if the degradation occurred anywhere within a 
transcript, amplification of a larger portion of the mRNA would be detectable. cDNA 
produced from the Stability Study sample #2 from day 0 and from day 2 was amplified 
using mixed primer combinations (see Table 10). PCR products were assessed via 





Figure 19.  Amplification with Flanking Primers for Intact Determination. The 
primers used and expected products are as described in Table 10. Reactions using the 
flanking primers (L) resulting in larger sized fragments reinforces the presence of intact 
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Table 11. Agarose Gel Contents for mRNA Intact Determination. The contents of 
each well and expected product length for each reaction from the agarose gel in Figure 
19.  Lanes 2 through 13 represent the day 0 extraction from sample 2 in the stability study 
while lanes 15 through 26 represent the day 2 extraction from sample 2.  




Location on gel Lane contents/ 
primers used 
Lane 1 100bp ladder  Lane 14 100 bp ladder 
Lane 2 CLK F/ CLK R 119 bp Lane 15 CLK F/CLK R 
Lane 3 LCLK F/ CLK R 730 bp Lane 16 LCLK F/ CLK R 
Lane 4 CLK F/ LCLK R 800 bp Lane 17 CLK F/ LCLK R 
Lane 5 LCLK F/ LCLK R 1411 bp Lane 18 LCLK F/ LCLK R 
Lane 6 Per3 F/ Per3 R 115 bp Lane 19 Per3 F/ Per3 R 
Lane 7 LPer3 F/ Per3 R 504 bp Lane 20 LPer3 F/ Per3 R 
Lane 8 Per3 F/ LPer3 R 1047 bp Lane 21 Per3 F/ LPer3 R 
Lane 9 LPer3 F/ Lper3 R 1436 bp Lane 22 LPer3 F/ Lper3 R 
Lane 10 TPOH F/ TPOH R 101 bp Lane 23 TPOH F/ TPOH R 
Lane 11 LTPOH F/ TPOH R 663 bp Lane 24 LTPOH F/ TPOH R 
Lane 12 TPOH F/ LTPOH R 843 bp Lane 25 TPOH F/ LTPOH R 
Lane 13 LTPOH F/ LTPOH R 1403 bp Lane 26 LTPOH F/ LTPOH R 
 
 Bands of expected lengths were visible in all PCR products amplified with the 
different primer mixes although nonspecific bands were also sometimes present. A high 
number of cycles in PCR is necessary for successful amplification of low copy targets but 
often results in non-specific amplification.  To assure non-specific products were absent 
for quantitative analysis, melting curves were performed following amplification in 
qPCR. Results from the melting curves showed that no non-specific amplification was 





 The aim of this study was to determine if our experimental plan that included 
possible delays from collection to RNA extraction and reverse transcription would have 
an effect on the accuracy of qPCR results reflecting levels of gene expression in circadian 
clock genes. ANOVA comparison of means of samples extracted over an 8-day period of 
storage showed no statistically significant difference in the quantity of mRNAs markers 
studied. Additional evaluations with amplification of larger segments of the CLOCK, 
PER3 and TPOH genes confirmed that the mRNA remains largely intact and therefore 
extraction of RNA from a stain prepared 2 days earlier will not be significantly degraded. 
The existence of larger intact amplicons provides evidence that the qPCR data are 
reliable as indicators of the actual abundance of the transcripts and hence an accurate 
reflection of the level of gene expression.  Although this study validates mRNA stability 








PHYSIOLOGIC VARIATION STUDY 
 
 
Results and Discussion  
 The levels of many mRNA are expected to vary during the day due to exogenous 
and endogenous influences. For any study of gene expression involving the abundance of 
transcribed mRNA, it is important to know the amount of variation in RNA levels that is 
due to technical causes as well as the variation that may exist when testing the pool of 
unrelated subjects that provide the biological samples. Knowing the amount of variation 
that exists in a study allows an investigator to confidently detect changes in gene 
expression that result from environmental conditions, or changes that are the result of 
daily oscillations in gene expression that characterize the circadian rhythm. Accurate 
quantification of mRNA levels associated with rhythmic gene expression allows for the 
possibility of estimating time throughout a 24-hour day. In order to establish the normal 
range of expression for each circadian rhythm marker, blood samples were collected, on 
up to 4 occasions, from 8 volunteers at the same time of day over 3-week periods.   
Quantification or mRNA levels for the rhythmic markers was determined with qPCR and
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Cq results were normalized to S100A12 and to CLOCK mRNA expression levels. Male 
and female data were analyzed separately in consideration of possible sex-related 
differences in gene expression. Mean values, standard deviations and coefficients of 
variation were calculated to determinate the limits of variation in gene expression that an 
average individual may exhibit. Table 12. A gene that exhibits less variability may act as 
a more sensitive indicator of naturally changing levels. Thus, one purpose of these 
experiments was to identify those markers of circadian rhythm that are better able to meet 
our needs for estimating the time of day a blood stain was created. 
 
Table 12. Physiologic Variations Normalized to S100A12 and to CLOCK. Observed 
physiologic variation in mRNA levels quantified in blood stains obtained from an 
individual sample over three weeks’ time. Blood samples from eight volunteers were 
collected at the same time of day, three to four times over a period of up to three weeks 
for a total of 26 blood stains. Mean values were calculated from normalized (S100A12 
and CLOCK) Cq values and coefficients of variation were determined. Results in this 
table represent the observed amount of variation within the sample population of each 





















PER1  14.8 10.2 8.5 15.2 
PER 2 18.9 17.1 10.1 27.3 
PER 3 14.2 11.0 8.1 7.3 
BMAL1 37.2 29.4 18.2 24.7 
CLOCK 27.6 0 13.4 0 
CRY 1 20.7 22.2 10.7 24.2 
CRY 2 18.0 14.1 9.5 21.5 
Cye 11.5 12.5 11.1 17.4 
MKNK2 40.6 66.0 23.8 29.2 
THRA1 15.9 25.5 13.5 44.0 
TPOH 11.0 9.4 10.8 15.3 
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 Decreased variation and reliable gene expression levels define an optimal marker 
for time estimation. Ideal markers of circadian rhythm are those that exhibit a predictable 
pattern of abundance over a 24-hour period and whose mRNA levels fall within a narrow 
range of expression at defined points in time. It is possible that mRNA levels that exhibit 
a higher amount of variation may be influenced by factors outside of circadian rhythm 
and therefor may not be optimal for our purposes. In some cases, the excessive CV’s 
obtained in this study may be due to analytical sensitivities in the testing protocol or in 
the instrumentation used. Cq levels of greater than 30 represent sparse target mRNA thus 
reproducibility may be problematic. Decreased amounts of mRNA may also exhibit a 
higher sensitivity to degradation and to stochastic effects.  
 Additional sample analysis could reduce CV values although this study was 
performed in order to screen markers for later applications.  The data from this study 
represents one time point in a 24-hour day, therefore this approach does not generate 
peaks and troughs of gene expression during the 24-hour cycle. Based upon this analysis, 
no markers were dropped from this study. Information generated here contributed to the 
overall understanding of rhythmic marker expression and detection in blood samples. 
 
Conclusion  
 Optimal markers for time determination exhibit lower variations of predictable 
rhythmic expression and therefore have the potential to be reliable markers for time 
estimation. Expression levels of BMAL1 and MKNK2 in men and women normalized to 
CLOCK and S100A12 appear too variable for a reliable indicator of time. Additionally, 
CRY1 normalized to both CLOCK and S100A12 and THRA1 normalized to CLOCK 
92 
 
exhibit a wide range of expression at one time point in women. Furthermore, PER2, 
CRY1, CRY2, and THRA1 normalized to CLOCK all exhibit large ranges of expression 
that consequently may reduce the efficacy in time determination applications. Although 
some of the markers exhibited a large variation of expression at one time point, mRNA 
peak and trough levels at different points in the 24-hour period may have a large enough 
difference to overcome the variability. These observations will be considered as 





















AGE-RELATED VARIATION STUDY 
 
 
Results and Discussion  
 In order to reduce variability in mRNA abundance levels between samples, 
experiments were performed to identify sources of variability that affect the 
reproducibility of mRNA abundance quantitation and establish the thresholds of 
significance for the cyclic expression of markers during the circadian rhythm.  Accurate 
estimates of the time of day a stain was created will depend upon comparing RNA levels 
in a crime scene sample against a reference curve that plots RNA abundance versus the 
time of day a stain was created. Since age-related changes in rhythmic gene expression 
levels is well documented (Hood & Amir, 2017; Yu, Hazelton, Luebeck, & Grady, 2019), 
we sought to evaluate the age related differences in expression of our panel of circadian 
markers. Volunteer blood donors were divided into 4 age categories (20-29, 30-39, 40-49, 
and 50-59) to assess whether or not differences exist between age groups in the rhythmic 
expression of genes of interest. Forty samples were collected at 1:00pm +/- 30 minutes 
and assessed for age-related variations in the expression of eleven genes. Rhythmic 
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markers included PER1-3, CRY1-2, BMAL1, CLOCK, CYE, MKNK2, THRA1 and TPOH. 
S100A12 or CLOCK were used to normalize data. Quantitative PCR was performed in 
triplicate for each marker and normalized to either S100A12 or CLOCK.  Mean values, 
standard deviations and coefficients of variation were calculated for each age group 
(Tables 13 and 14). A one-way ANOVA with a post hoc Tukey Test was performed 
using Prism 8™ GraphPad (GraphPad Software, San Diego, CA). No significant 





Table 13. Comparison of Expression Levels Normalized to S100A12 Based on Age. 
Cq values were normalized to S100A12 and were compared using a one-way ANOVA 
analysis and post hoc Tukey’s Test on Prism™ GraphPad (GraphPad Software, San 
Diego, CA). Observed variations in each marker and age group is expressed as the 
coefficient of variation (CV). No significant difference was observed between age groups 
when expression levels were normalized to S100A12. (average p-value = 0.9528) 
 20's 30's 40's 50's 
 
Mean Cq CV 
Mean 
Cq 
CV Mean Cq CV Mean Cq CV 
PER1 9.30 13.9% 10.42 10.1% 8.91 10.3% 9.55 17.7% 
PER2 7.05 14.3% 8.48 12.1% 6.79 9.8% 7.60 18.2% 
PER3 9.80 10.1% 10.38 8.0% 9.17 9.1% 9.77 10.0% 
BMAL1 3.10 15.2% 3.73 19.6% 2.50 32.2% 3.27 28.4% 
CLOCK 5.05 13.4% 5.87 13.1% 4.15 20.4% 5.25 21.9% 
CRY1 5.98 14.5% 7.03 12.8% 5.59 14.0% 6.96 22.8% 
CRY2 6.82 9.7% 8.05 11.8% 6.84 15.9% 6.96 12.4% 
CYE 9.21 13.9% 10.17 11.9% 9.37 11.6% 7.68 6.6% 
MKNK2 3.53 44.7% 4.32 26.7% 3.72 18.1% 10.41 16.5% 
THRA1 6.96 15.9% 7.79 16.2% 6.83 10.5% 8.33 8.3% 







Table 14. Comparison of Expression Levels Normalized to CLOCK Based on Age. 
Cq values normalized to CLOCK and were compared for differences between age groups 
with a one-way ANOVA test using Prism™ GraphPad (GraphPad Software, San Diego, 
CA). Comparison of means between groups was performed using a post hoc Tukey’s Test 
to detect differences between groups. No significant difference was observed between 
age groups in the mRNA tested when expression levels were normalized to CLOCK. 














PER1 4.24 21.0% 4.54 12.6% 4.73 8.6% 4.52 18.3% 
PER2 2.00 34.3% 2.54 17.4% 2.68 10.7% 2.66 24.4% 
PER3 4.74 10.7% 4.70 8.1% 4.96 6.9% 5.06 5.1% 
BMAL1 -1.96 18.4% -2.16 14.4% -1.67 19.8% -1.98 17.5% 
CRY1 0.92 28.8% 1.19 19.8% 1.37 13.5% 1.28 23.4% 
CRY2 1.86 19.7% 1.85 14.1% 2.03 7.9% 1.28 15.2% 
CYE 4.15 14.9% 4.22 13.6% 4.61 11.9% 2.01 15.5% 
MKNK2 -1.53 72.9% -1.70 40.1% -1.58 60.4% 4.46 80.4% 
THRA1 1.96 30.7% 1.71 35.1% 2.53 42.0% 2.23 42.4% 
TPOH 4.61   18.1% 4.23   14.6% 4.97   14.5% 4.78   14.4% 
 
 Although no significant differences were observed between age groups, 
differences between sexes were suspected. Therefore, it was important to re-evaluate data 
to determine if different expression levels exist between males at different ages as well as 
in females of different age.  This question was analyzed using the data collected for the 
age-related study described above (Table 13 and 14) thus data were further separated by 
sex. Once separated by sex, age related differences were again determined using a one-
way ANOVA with a post hoc Tukey’s Test on Prism™ GraphPad (GraphPad Software, 
San Diego, CA). Significant differences between age groups in females as well as in 
males were not observed. (Tables 15 and 16).  Subsequently, all female data was 
combined, regardless of age, and compared to combined male data for each marker tested 
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to examine if significant sex-related differences in mRNA levels exist between males and 




 Table 15. Age Comparisons Between Males and Females Normalized to S100A12. 
Mean values and coefficients of variation of each age group that were separated by sex 
are listed. The total column indicates the overall mean of combined ages in female and 
the overall mean of combined ages in males for each marker. The coefficients of 




 20's 30's 40's 50's Total 
PER1 Mean CV Mean CV Mean CV Mean CV Mean CV 
Female 9.74 15% 11.03 8% 9.42 17% 9.53 16% 9.98 14% 
Male 8.9 13% 9.81 12% 8.39 2% 9.56 19% 9.29 14% 
PER2           
Female 7.36 16% 9.03 10% 7.02 21% 7.07 18% 7.69 18% 
Male 6.73 0.13 7.92 14% 6.55 1% 7.51 18% 7.31 15% 
PER3           
Female 9.93 13% 11.12 9% 9.44 17% 9.19 11% 9.98 14% 
Male 9.67 8% 9.63 7% 7.51 15% 10.34 9% 9.73 9% 
BMAL1           
Female 3.32 11% 3.92 21% 1.91 65% 2.82 23% 3.04 36% 
Male 2.88 19% 3.53 18% 3.09 12% 3.50 22% 3.31 19% 
CLOCK           
Female 4.74 15% 5.84 16% 3.82 38% 4.83 20% 4.86 25% 
Male 5.36 12% 5.90 11% 4.48 5% 6.31 22% 5.66 19% 
CRY1           
Female 5.77 16% 7.09 14% 5.40 25% 6.20 13% 6.16 19% 
Male 6.18 13% 6.97 11% 5.78 4% 7.76 26% 6.85 20% 
CRY2           
Female 7.03 13% 8.45 11% 7.18 27% 7.65 12% 7.62 17% 
Male 6.60 6% 7.64 13% 6.49 4% 7.74 8% 7.26 12% 
CYE                     
Female 8.72 7% 10.49 15% 9.92 21% 10.80 9% 9.86 16% 
Male 9.69 20% 9.84 8% 8.82 1% 10.02 4% 9.73 10% 
MKNK2           
Female 3.67 46% 4.69 30% 4.36 30% 5.15 9% 4.38 31% 
Male 3.38 44% 3.94 23% 3.08 2% 4.07 26% 3.76 27% 
THRA1           
Female 6.80 12% 8.13 18% 7.73 17% 8.77 2% 7.68 16% 
Male 7.12 20% 7.44 15% 5.93 2% 7.89 16% 7.32 17% 
TPOH           
Female 9.04 7% 10.88 19% 10.21 15% 11.28 9% 10.35 15% 
Male 10.4 16% 9.9 7% 8.75 2% 9.81 10% 9.81 10% 
99 
 
Table 16. Age Comparisons Between Males and Females Normalized to CLOCK. 
Mean values of qPCR Cq results were normalized to CLOCK for each age group in males 
and females. The total column indicates the average normalized Cq values in all age 
categories in females and the combined normalized Cq values in all ages of males for 
each marker tested. The coefficients of variation for males and females are included.  
 20's 30's 40's 50's Total 
PER1 Mean CV Mean CV Mean CV Mean CV Mean CV 
Female 4.99 16% 5.17 7% 5.51 7% 5.12 12% 5.21 11% 
Male 3.5 28% 3.91 19% 3.91 11% 3.91 27% 3.82 19% 
PER2                     
Female 2.62 23% 3.05 10% 3.28 11% 2.97 10% 2.99 15% 
Male 1.37 0.55 2.02 29% 2.07 10% 2.35 43% 1.99 36% 
PER3                     
Female 5.18 16% 5.30 6% 5.49 9% 5.14 2% 5.28 9% 
Male 4.30 4% 4.09 10% 2.35 36% 4.98 8% 4.44 10% 
BMAL1                     
Female -1.41 -37% -1.94 -20% -1.94 -26% -2.01 -22% -1.83 -27% 
Male -2.49 -8% -2.37 -10% -1.39 -11% -1.94 -13% -2.08 -22% 
CRY1                     
Female 1.02 27% 1.30 17% 1.44 21% 1.37 18% 1.29 23% 
Male 0.82 31% 1.07 23% 1.30 5% 1.19 30% 1.10 26% 
CRY2                     
Female 2.29 17% 2.63 11% 2.75 9% 2.82 9% 2.62 13% 
Male 1.42 24% 1.74 23% 2.01 1% 2.11 41% 1.83 30% 
CYE                     
Female 3.98 8% 4.49 19% 4.83 20% 4.53 21% 4.49 18% 
Male 4.32 36% 3.94 8% 4.38 4% 4.39 10% 4.23 16% 
MKNK2                     
Female -1.08 -105% -1.44 -63% -0.70 -182% -1.00 -66% -0.98 -107% 
Male -1.98 -55% -1.95 -23% -2.46 -26% -1.40 -91% -1.88 -47% 
THRA1                     
Female 2.08 10% 2.01 34% 2.69 42% 2.73 21% 2.51 17% 
Male 1.76 51% 1.54 22% 1.58 10% 1.72 49% 1.64 17% 
TPOH                     
Female 4.32 14% 4.71 16% 5.19 13% 5.12 17% 4.83 15% 




 One-way ANOVA assays were again performed to compare male versus female 
qPCR (Cq) values for all markers that were normalized to S100A12 or CLOCK. No 
significant differences were observed in S100A12 normalized data between males and 
females, but significant differences were revealed between males and females in some of 
the markers observed when normalized to CLOCK. Figure 20 and 21. 
  
 
Figure 20. Female and Male Data Normalized to S100A12. qPCR Cq values for males 
and females were normalized to S100A12. Each column represents the combined mean of 
all male or female data regardless of age. Error bars represent the standard error for each 
marker. Significant differences were not observed in the markers tested when qPCR Cq 





































Figure 21. Female and Male Data Normalized to CLOCK. Columns represents the 
average of all CLOCK normalized Cq values in females and in males for each gene 
tested. Error bars denote the standard error for each marker. Significant differences were 
observed between males and females when Cq values were normalized to CLOCK. 
Statistically significant differences are denoted with an asterisk (*) and p values listed in 







































Table 17. Male and Female Differences in CLOCK Gene Expression Levels. One-way 
ANOVA analysis was calculated using Prism™ GraphPad (GraphPad Software, San 
Diego, CA) to compare between means and a post hoc Tukey’s Test was used to compare 
between groups. No statistical difference was observed between male and female data 
when Cq values were normalized to S100A12. ANOVA analysis of CLOCK normalized 
mean exhibited several significant differences (p-values <0.5 and denoted by “*”). 
 
mRNA evaluated for 
Female vs Male 
expression 




PER1 0.9910 <0.0001 * 
PER2 >0.9999 0.006 * 
PER3 >0.9999 0.160 
BMAL1 >0.9999 .9998 
CLOCK 0.9519 NA 
CRY1 0.9922 >0.9999 
CRY2 >0.9999 0.0363* 
CYE >0.9999 0.9998 
MKNK2 0.9992 0.0112 * 
THRA1 >0.9999 0.0539 
TPOH >0.9999 0.8912 
 
Conclusion 
 There was no significant difference in the circadian rhythm markers between age 
groups (20’s to 50’s) when Cq values were normalized to S100A12 or to CLOCK. 
Additionally, there was no significant differences in data normalized to CLOCK or 
S100A12 observed between age groups in women or in men when compared separately. 
Thus, no significant difference was observed in data normalized to S100A12 or CLOCK 
in the genes tested based on age. 
 There was, however, a significant difference between men and women in 
expression levels of several of the circadian rhythm genes tested. Therefore, male and 










24 HOUR EXPRESSION PATTERN STUDY 
 
 
Results and Discussion 
 Eleven genes associated with circadian rhythm have been characterized for 
stability, and for differences in expression among age groups and sexes during a 24-hour 
period. Messenger RNA levels for each gene were quantified using qPCR and expression 
levels were normalized against the abundance of mRNA transcribed from either the 
S100A12 or CLOCK genes whose expression appeared stable throughout the 24-hour 
time period. To establish the expression of a gene varied in a rhythmic way, it was 
necessary to quantify the variation that might exist in our RNA quantity estimates 
originating from gene expression differences among members of our blood donor 
population (i.e. individual variations in gene expression or variation in gene expression in 
males versus females). The understanding gained from our analyses of RNA 
quantification data allowed for the creation of a reference pattern of gene expression 
range for each marker analyzed. This reference range allowed for the confident 
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identification of genes rhythmically expressed over the day and also can allow for 
estimates of when during the day a forensic blood stain was created.   
 Blood samples were collected every 4 hours for a 24-hour period. Defined 
collection times included 4:00 am, 8:00 am, 12:00 pm, 4:00 pm, 8:00 pm, and midnight. 
Blood samples were collected within 30 minutes of these target collection times. Dried 
blood stains were submitted to the laboratory within 24 hours of the collection and stain 
preparation. All blood samples (6) from each collection time period were extracted 
simultaneously. Reverse transcription and DNAse treatment immediately followed 
extraction in all cases. The cDNA samples were immediately frozen at -20°C until being 
analyzed using qPCR. 
 Quantitative PCR for each collection time was performed for each marker in 
triplicate. Triplicate results were averaged and normalized to expression of the S100A12 
and/or CLOCK for prior to downstream analysis of the quantification data.  There are 6 
figures representing the relative expression data for each gene analyzed. The first 3 
graphs of each marker represent data normalized to S100A12 in which expression data in 
males and females is combined and also data separated by sex. The second set of three 
graphs for each marker represent the same analysis but the data have been normalized to 
CLOCK gene expression. A One-way ANOVA and a post hoc Tukey’s Test were 
performed to compare the means of each time point and determine if a significant 









Figure 22. PERIOD 1 24-Hour Expression Normalized to S100A12. Twenty-four 
expression levels of PERIOD 1 normalized to S100A12 in all samples and separated into 
male and female samples. Standard error bars indicate the large variation in expression 
levels at each time point. There is no discernible rhythmicity observed when normalizing 
PER1 to S100A12 in either male, female or combined populations. There are no 
significant differences between any time point. PERIOD 1 mean Cq values ranged from 































































Figure 23. PERIOD 1 24-Hour Expression Normalized to CLOCK. PER1 data 
normalized to CLOCK combined and separated by sex. Standard error bars are reduced 
compared to Period 1 results normalized to S100A12.  Rhythmicity is not observed in any 
of the data although error bars are reduced compared to S100A12 data. There are no 
statistically significant differences between any time point observed. PER1 mean Cq 






























































Figure 24. PERIOD 2 24-Hour Expression Normalized to S100A12. PER2 Cq values 
normalized to S100A12 in all samples combined and separated by sex. Rhythmicity 
appears neutralized by the sizeable standard errors at each time point in males and 
females. Additionally, the trend is reduced when the data is combined. There is no 
statistically significant difference between any time points in the time points observed in 
PER2 normalized to CLOCK. PERIOD 2 mean Cq values ranged from 27.2 to 31.5 and 































































Figure 25. PERIOD 2 24-Hour Expression Normalized to CLOCK. PER2 Normalized 
Cq data was observed combined and separated into male or female samples. Standard 
error bars are reduced from those observed when normalized to S100A12 although there 
is still no evident rhythmicity observed in PER2 normalized to CLOCK. There is no 
statistical significance between any time point in the 24-hour samples observed of PER2 
normalized to CLOCK. PER2 mean Cq values ranged from 27.2 to 31.5 and CLOCK 































































Figure 26. PERIOD 3 24-Hour Expression Normalized to S100A12. Combined male 
and female data exhibit a subtle trend in expression from 8:00am to 12:00pm. The change 
in expression is more pronounced when observed in female samples alone. Smaller 
standard error bars represent reduced variability in expression levels. There are no 
statistically significant differences between time points when male and female data are 
combined or in male data alone. There are statistically significant differences in female 
PER3 data normalized to S100A12 between 12:00 am and 8:00 pm (p=0.0250) and 4:00 
am and 8:00 pm (p=0.0297). PERIOD 3 mean Cq values ranged from 28.7 to 34.8 and 
































































Figure 27. PERIOD 3 24-Hour Expression Normalized to CLOCK. PERIOD 3 
normalized to CLOCK in all samples combined, and in separated male or female samples. 
There is no observed pattern in male samples normalized to CLOCK and standard error 
bars indicate a large variation in expression at most time points. Combined results exhibit 
a rhythmic pattern although when observed separately, the female sample exhibit 
rhythmicity with reduced variance throughout the collection period. There is a 
statistically significant difference in combined data between 4:00 am and 8:00 pm 
(p=0.0271) although most likely attributed to female data. Rhythmicity is observed in 
female PER3 Cq values normalized to CLOCK with a statistical significant differences 









































































am and 4:00 pm (+) (p=0.0014), 4:00 am to 8:00 pm (^) (p=0.0427), 8:00 am to 12:00 pm 
(<) (p=0.0162), and 8:00 am to 4:00 pm (>) (p=0.0028) PER3 mean Cq values ranged 




Figure 28. BMAL1 24-Hour Expression Normalized to S100A12. BMAL1 Cq values 
normalized to S100A12 in all samples combined and in male and female separated 
samples. Enlarged standard error bars indicate a large variation in expression in all 
sample groups. There is no statistically significant difference between time points when 
BMAL1 is normalized to S100A12. BMAL1 mean Cq values ranged from 23.8 to 29.8 and 
































































Figure 29. BMAL1 24-Hour Expression Normalized to CLOCK. BMAL1 Cq values 
were normalized to CLOCK and all data were observed together and separated by sex. 
Standard error bars indicate a high level of variance while no apparent rhythmic pattern is 
observed. Additionally, there are no statistically significant differences between time 
points. BMAL1 mean Cq values ranged from 23.8 to 29.8 and CLOCK results ranged 



































































Figure 30. CRYPTOCHROME 1 24-hour Expression Normalized to S100A12. CRY 1 
Cq values were normalized to S100A12 and assessed together and then reassessed 
separately by sex. Combined data appear flat with large variations indicated by the 
standard error bars. When the data is observed separately, trends are present although 
standard error bars, representing variation at each time point, remains elevated. There are 
no statistically significant differences in expression levels between time points. CRY1 






























































Figure 31. CRYPTOCHROME 1 24-Hour Expression Normalized to CLOCK. CRY 1 
qPCR data normalized to CLOCK in males, females and when all data was combined. 
There is no rhythmicity observed and there is no statistically significant difference 
between time points in any CLOCK normalized CRY1 time points evaluated.  Standard 
error bars represent the amount of variation at each time point. CRY1 mean Cq values 
ranged from 26.5 to 33.3 and CLOCK results ranged from 25.0 to 31.2. It is interesting to 
speculate that the large range of expression of CRY1 in males may reflect individual 
differences among male donors in the expression gene. There is no reason to suspect a 

































































Figure 32. CRYPTOCHROME 2 24-Hour Expression Normalized to S100A12. CRY2 
was normalized to S100A12 and the data was platted on a line graph Female, male and 
combined data were evaluated for rhythmic trends, variability and statistically significant 
differences between time points.  An increase in CRY2 was observed from 12am to 8pm 
in female samples although the higher standard error values reduce the statistical 
significance between points. Combined data and male only data exhibit highly variable 
nonrhythmic patterns. There are no statistical significance differences between time 
points. CRY2 mean Cq values ranged from 26.9 to 32.0 and S100A12 results ranged from 


























































Figure 33. CRYPTOCHROME 2 24-Hour Expression Normalized to CLOCK. CRY2 
Cq values normalized to CLOCK were observed together and after separation in male and 
female groups. There is no observed rhythmic pattern over the 24-hour collection period 
although the variability is reduced, as seen by the smaller error bars. There are no 
statistically significant differences between time points. CRY2 mean Cq values ranged 































































Figure 34. CYE 24-Hour Expression Normalized to S100A12. CYE normalized to 
S100A12 in male, female and in all samples combined. Larger standard error bars 
represent an increase in variance at a specific time point. Possible rhythmic expression is 
observed in female CYE that is normalized to S100A12. Male data shows no rhythmicity 
thus the combined data exhibit a muted rhythmic expression when males and females are 
combined. There are no statistically significant differences between time points. CYE 































































Figure 35. CYE 24-Hour Expression Normalized to CLOCK. CYE normalized to 
CLOCK exhibits a rhythmic pattern of expression over a 24-hour period in females. No 
rhythmic pattern of expression was observed in male samples thus combined data 
exhibits a muted rhythm. Standard error within time periods nullifies the difference 
observed at each time point. There was no statistically significant difference between 
time points observed. CYE mean Cq values ranged from 29.2 to 35.3 and CLOCK results 



























































Figure 36. MKNK2 24-Hour Expression Normalized to S100A12. MKNK2 normalized 
to S100A12 in male, female and combined data. Rhythmicity is observed although 
extensive variability, indicated by the standard error bars, reduces the difference between 
time points.  There are no statistically significant differences between time points. 

































































Figure 37. MKNK2 24-Hour Expression Normalized to CLOCK. MKNK2 normalized 
Cq values were assessed together and after separation into groups consisting of males, 
and females. Rhythmicity is not observed in any group when normalized to CLOCK. The 
large standard error bars indicate a wide range of expression at most time points. There is 
no statistically significant difference between time points. MKNK2 mean Cq values 





































































Figure 38. THRA1 24-Hour Expression Normalized to S100A12. THRA1 qPCR Cq 
values normalized to S100A12 were assessed together and after separation into male and 
female groups.  Standard error bars reflect the variability in expression present at each 
time interval. A pattern of expression is observed in females although the variability 
observed at each time point reduces the efficacy of THRA1 as an accurate indicator of 
time. Data from males and combined male and female data lack rhythmic expression 
when normalized to S100A12. There is no statistically significant difference between time 
points when THRA1 Cq values are normalized to S100A12. THRA1 mean Cq values 






























































Figure 39. THRA1 24-Hour Expression Normalized to CLOCK. THRA1 Cq values 
normalized to CLOCK in males, females and in combined data. No discernible 24-hour 
pattern of expression in males is observed while females exhibit a rhythmic pattern of 
expression. Variability seen in the standard error bars reveals extensive variability in 
female samples consequently there are no statistically significant differences between 
time points in THRA1 Cq values normalized to CLOCK. THRA1 mean Cq values ranged 

























































Male THRA1 Normalized to CLOCK
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Figure 40. TPOH 24-Hour Expression Normalized to S100A12. Quantitative PCR Cq 
values for TPOH normalized to S100A12 exhibit a subtle pattern of expression over 24 
hours in female data. Combined and male data exhibit constant levels of expression 
throughout the day when standard error results are considered.  There are no statistically 
significant differences between time points in Cq values normalized to S100A12. TPOH 































































Figure 41. TPOH 24-Hour Expression Normalized to CLOCK. TPOH Cq values were 
normalized to CLOCK and observed together and separated by sex. A rhythmic pattern is 
observed in the combined data and in male only results. Female data contains a large 
amount of variation per time point as indicated by the standard error bars. Expression 
variability in male data exhibits minimal variation of expression at each time point and 
statistically significant differences were observed between 12:00 am and 4:00 pm (*) 
(p=0.0278) and 12:00 am to 8:00 pm (#) (p=0.0304). TPOH mean Cq values ranged from 


































































Figure 42. CLOCK 24-Hour Expression Normalized to S100A12. Comparison of 
CLOCK and S100A12 expression appear stable throughout the 24-hour collection period 




































































Male CLOCK Normalized to S100A12
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 Earlier research established that S100A12 and CLOCK are expressed at constant 
levels throughout the day (Bjarnason et al., 2001) although normalizing with S100A12 
versus CLOCK frequently resulted in different outcomes in rhythmic patterns and 
standard error. S100A12 is a Ca+ binding protein involved in proinflammatory responses 
and expression is normally associated with neutrophils. Neutrophils normally constitute 
55% to 65% of the white blood cells in the peripheral blood but may increase to 75% or 
more during bacterial infections and inflammatory conditions.  
 In contrast, CLOCK is a key component in the heteroduplex of the 
BMAL/CLOCK heterodimer that drives circadian rhythm. Since the peripheral blood is 
composed of multiple cell lineages (red blood cells, platelets, neutrophils, lymphocytes, 
monocytes, eosinophils and basophils) it is possible that expression levels for both 
circadian rhythm genes and the genes their expression is normalized against may vary in 
complex ways among the blood cell lineages. While previous studies of circadian rhythm 
investigated different tissue types, often those tissues consisted of a histologically similar 
populations of cells with the expected homogeneity of gene expression. In extensions of 
this work, it will be important to connect the gene of interest with the hematopoietic cell 
lines that express it.  
 Cell specific expression of circadian rhythm genes was available from 
GeneCards® The Human Gene Database (LifeMap Sciences Inc. Carlsbad, CA). 
Expression levels for each gene studied is shown in whole blood, white blood cells and in 
lymph node (representative of the lymphocyte population) samples in Table 16. From this 
information, it appears there is a greater amount of S100A12 in white blood cells than in 
the lymph node. This data correlates with the findings of Hou (2015) that showed 
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S100A12 in peripheral blood is expressed by neutrophils, monocytes and macrophages 
(Hou, 2015).  Thus, when more target mRNA is found in lymph nodes than in white 
blood cells, those differences can be attributed to a larger expression in lymphocytes over 
other white blood cells. Conversely, when a larger amount of expression is seen in the 
white blood cells than in lymph nodes, lymphocytes most likely demonstrate a lower 
level of expression.   
 
Table 18. Expression Levels of Selected Genes by Cell Population. Whole blood 
contains red blood cells, platelets and white blood cells (neutrophils, lymphocytes, 
monocytes, eosinophils and basophils).   The lymph node represents mainly lymphocytes 
with a smaller population of monocytes/macrophages. Fragments per kilobase of exon 
per million fragments mapped (FPKM) normalizes the amount of target RNA detected. 
(*)Fragments Per Kilobase of exon per million fragments mapped (FPKM). 
Marker Whole Blood  
(110x FPKM)1/2 * 
White Blood Cells 
(110x FPKM)1/2 * 
Lymph Node  
(110x FPKM)1/2 * 
S100A12 495 264 47 
CLOCK 7 19 18 
PER1 65 18 34 
PER2 10 14 12 
PER3 4 10 11 
CRY1 11 27 31 
CRY2 20 27 31 
CYE 7 8 12 
MKNK2 84 82 74 
THRA1 16 25 37 
TPOH 2 1 3 
Data from Gene Card (https://www.genecards.org) 
  
 The differences in gene expression levels observed in samples normalized to 
S100A12 versus CLOCK can be attributed to the cell population that expresses the marker 
of interest and to the appropriate marker used to normalize those expression levels. The 
distribution of cells in an individual adds an additional caveat to the complexities 
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involved. Quantification of mRNA that is expressed in lymphocytes but normalized to a 
neutrophilic marker may not only be ineffective, but in the presence of an inflammatory 
condition, exaggerates the error. Additionally, neutrophils exhibit a diurnal pattern in cell 
numbers that results in a state of pseudoneutropenia in the morning due to a rhythmic 
expression of granulocyte colony stimulating factor (GCSF) stimulating neutrophil 
release from the bone marrow (Jilma et al., 1999). The circadian cycles of neutrophils 
introduce an additional complication to 24-hour data interpretation. Therefore, the 
difference in expression patterns and standard errors when normalizing to S100A12 or to 
CLOCK can be attributed to normalization of Cq values for the rhythmic marker to a 
constitutively expressed gene in a cell of the same closely related cell lineage. 
Regardless of the complexities of our experimental system, it appears that a reference 
range of expression for PER3 in females and TPOH in males can be defined with 
expression levels in morning and night that are statistically different. If the sex of a 
sample is known, the expression profiles for PER3 (females) and TPOH (males) could 
distinguish between a stain created in the morning versus one created at night. 
 
Conclusion 
 Ideal candidates for time determination are those markers that have minimal 
variation at each time point assessed and exhibit a 24-hour rhythmic expression. Of the 
11 circadian genes assessed, PERIOD 3 normalized with CLOCK shows minimal 
variation and statistically significant differences between time points. PERIOD 3 
normalized to CLOCK has the potential to indicate a 12-hour window of time in which a 
female blood stain was created. In males, the expression of TPOH, normalized to 
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CLOCK, exhibits a 24-hour rhythmic pattern of expression with very little deviation from 
each time point assessed.  TPOH can potentially determine an 8-hour time period from a 



























 Circadian rhythm is a continuous regularly oscillating pattern of gene expression 
and behavior exhibited by living organisms. This rhythm is stimulated by both exogenous 
and endogenous factors and can be observed through cyclic biologic processes. Because 
biologic processes often involve interactions with proteins translated from mRNA that 
are transcribed from cyclically expressed genes, the timely fluctuations of RNA levels 
provide a means to identify points in circadian 24-hour cycles.  
 One means of regulating gene expression is through epigenetics modifications of 
nucleic acids and proteins that can act to control mechanisms influencing both 
transcription and translation. Since epigenetic effects can be observed through the 
chemical modification of DNA, the time of day may be correlated with modifications 
such as methylation and may offer an alternative approach to estimate time. PERIOD 1-3, 
CRYPTOCHROME 1-2, NPAS2 and BMAL1 methylation patterns were assessed using 
DNA extracted from blood stains collected every 4 hours for a 24-hour period. 
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Comparisons of likely methylation targets in the PER1-2, CRY1-2, NPAS2 and BMAL1 
genes were assessed using a PCR protocol designed to distinguish between methylated 
and unmethylated sequences. PERIOD 3 was the only gene target that exhibited 
methylation and the methylation detected was nominal and unchanging at every time 
point.  All other markers were negative for methylation at all time points tested. Results 
from the methylation study revealed that methylation of the selected DNA markers in 
dried blood stains is not correlated with the circadian rhythm and therefore this approach 
is not useful to estimate the time of day a blood stain was created. 
 Because there are a multitude of factors contributing to the complex orchestration 
of transcription and translation during the circadian rhythm, the study of mRNA 
abundances as a measure of rhythm during the daily cycle was logical as one approach 
for defining the cycle throughout the day. Messenger RNAs transcribed from genes 
shown previously to vary in expression in a cyclic manner in dried blood stains were 
analyzed at defined time points during a 24-hour period. In order to accurately assess and 
compare levels of mRNA it was first necessary to confirm that the target mRNA did not 
degrade during the time that passes between sample collection and RNA extraction from 
dried stains. Because the mRNA levels of the targeted genes tended to be low, there was 
concern that lower amounts of mRNA would be susceptible to even small amounts of 
degradation. Blood stains were collected and stored for varying periods before extracting 
RNA that was subsequently quantified for transcripts from several rhythmically 
expressed genes. Results showed no significant degradation within an 8-day period of 
storage. Transcript quantities for all of the studies reported here were obtained using 
RNA extracts prepared within 48 hours of sample collection. 
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 In order to establish the fluctuations of mRNA quantities during the daily cycle 
with validity, it was important to establish the extent to which the expression of targeted 
genes fluctuate naturally. To investigate naturally occurring variation in transcript levels, 
blood samples were collected at the same time of day from donors over several weeks.  
Extractions were performed within 48 hours of collection and qPCR was used to quantify 
mRNA levels. Most of the markers exhibited less than a 15% variation in abundance 
when mRNA levels were normalized to S100A12. This value rose to ~20% variation 
when mRNA levels were normalized to CLOCK. Observations from this study help to 
define reference profiles of gene expression during the circadian rhythm. Such reference 
profiles will be useful to estimate the time of day biological evidence was created at a 
crime scene. 
 The ability to estimate the time a blood stain was deposited at a crime scene 
requires a reference pattern of gene expression that correlate with defined times 
throughout a 24-hour period. For this study, it was important to explore the feasibility of 
creating a reference pattern of gene expression using blood stains created at known times 
during the day using blood donors whose daily habits are representative of those of the 
population general. Thus, the reference pattern of gene expression created here was from 
blood donors whose sleep habits and daily routines were somewhat known. The question 
arose as to whether age differences among blood donors might affect RNA levels. Donor 
groups selected by age were evaluated in the Age Comparison Study. Volunteers were 
separated into age categories and blood was collected from each volunteer at the same 
time of day. Quantitative PCR was performed and Cq values were normalized. Mean 
values were compared to determine if age effected mRNA expression levels. There was 
133 
 
no significant difference observed in the abundance levels of the transcripts tested among 
the age categories. There was, however, significant difference in gene expression 
between males and females regardless of age. These findings demonstrate that, although 
there is no age-related difference in gene expression for the circadian markers studied, 
there is a need for separate reference patterns in males and females for the accurate 
assessment of time. 
 Eleven rhythmic genes associated with circadian rhythm were characterized for 
stability, and variability within an individual, and between sexes and age groups. This 
information was incorporated into the development of our experimental approach to 
defining a reference pattern of gene expression during the circadian rhythm. In these 
experiments, an attempt was made to determine if 24-hour expression patterns can be 
detected in blood stains. Blood stains were collected every 4 hours for 24 hours, RNA 
was extracted from the stains and converted to cDNA. The abundance of a group of 
selected mRNAs was determined using qPCR and Cq values were normalized to the 
transcripts of S100A12 and/or CLOCK genes. Mean Cq values, standard deviations and 
ANOVA analysis with a post hoc Tukey Tests was performed on all data. Transcript 
abundance values for each marker was assessed for male and female donors together and 
separately.  
 Statistically significant differences in abundance between rhythm time points 
were observed for PERIOD 3 mRNA levels in females when normalized to CLOCK. The 
reference pattern of PERIOD 3 gene expression in female blood stains has the potential to 
define a 12-hour window of time during the day. Likewise, statistically significant 
differences in TPOH gene expression in males were observed when TPOH mRNA levels 
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were normalized to CLOCK.  Using this reference pattern, it may be possible to define an 
8-hour window of time during the day in male blood stains. 
 The goal of this research project was to explore if it is feasible to determine when 
during a 24-hour day a blood stain was created at a crime scene. The results of this study 
are encouraging as to the feasibility of using the cycling patterns of gene expression 
during the day as a forensic tool for the furtherance of a criminal investigation. With a 
sufficient number of circadian rhythm markers included in the analysis, it could be 




 More cyclic genes exhibiting low variability need to be identified to increase the 
sensitivity of time determination and narrow the window of time that can be identified. 
Because approximately 10 % of mRNA is expressed rhythmically (Doherty & Kay, 
2010) and eleven genes were targeted in this study, there is a great opportunity to further 
this research. The ability to identify time from a single blood stain could improve the 
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APPENDIX B: Participant Information and Consent Form 
 
PARTICIPANT INFORMATION AND CONSENT FORM 
 
Title of Project: Age estimation of body fluid stains using a novel qPCR methodology  
Investigator: Robert W. Allen, PhD, School of Forensic Sciences, 918-561-1292  
 
You are being asked to participate in a research study by donating small samples of blood. If this 
consent form contains any words you do not understand, please ask the investigator to explain 
these words so that you understand them. This consent form contains important facts to help 
you decide if it is in your best interest to take part in this study.  
In order to contribute a sample, you must:  
• Be at least 18 years old  
• Have (or be in the process of obtaining) a basic knowledge of molecular biology or a 
related field such that the overall goals of this project could be understood.  
• Be willing to provide a blood sample with which to prepare dried stains that can be used 
as a source of RNA for analysis.  
No identifying information (your name, address, social security number, etc.) will remain with 
the biological sample(s) collected from you. All samples upon collection will be assigned an 
identification number that will remain with the sample throughout analysis. The decision of 
whether to participate or not is completely up to you. If you decide not to sign this form, there 
will be no consequences for your decision.  
I. What is the purpose of this research?  
The investigation of a crime strives to answer the questions of who, what, where, and when 
so that the events surrounding a crime can be reconstructed. Of the questions posed above, 
the question of when is often the hardest to answer. The question of when has relevance in 
trying to determine when someone died (the postmortem interval) and when a biological 
sample of evidence was left at a crime scene. 
In earlier research performed in this laboratory, we have been able to estimate the age of 
blood stains using a molecular assay involving quantitative PCR (qPCR) in which the 
degradation of specific mRNA transcripts correlates well with sample age. The purpose of 
this research is to determine the time of day a sample is collected based on cyclic expression 
of specific genes. 
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In addition, in preliminary studies, stains were prepared on inert bloodstain cards often 
used for the long-term preservation of biological fluids. Thus, the substrate upon which 
body fluid stains were prepared in our preliminary studies was also not representative of the 
substrates bearing stains at crime scenes and therefore the effect of the substrate on mRNA 
degradation is also to be assessed in this project. 
II. How many people will participate?  
 
This project will involve the collection of small blood samples (i.e. 05-1.0 cc) from 20-30 male 
and female donors (10-15 for each sex).  
 
III. What will you ask me to do if I want to participate in this study?  
 
If we find that you are eligible to give a sample, we will collect the sample type(s) that you have 
agreed to provide. Blood will be collected in the OSU CHS Human Identity Lab sample 
collection room under sterile conditions by a certified phlebotomist.  
• Blood: We will collect 0.5-1.0 cc's of blood from your arm or by fingerstick. Sallie 
Ruskoski will perform the venipuncture collections. Sallie is a Medical Technologist 
(ASCP) and has taught phlebotomy for the TCC Med Lab Tech program. She is currently 
the Director for the Medical Laboratory Sciences program at Northeastern State 
University.  
 
IV. What will happen with the sample I give you? 
 
The sample will be processed and stored at OSU-CHS. The only information included with the 
sample will be the sample identification number assigned to that sample upon collection 
that reflects the date and time of the collection and spotting of the samples to prepare 
stains.  
 
Processing and storage of the sample will include:  
• Deposition of biological samples onto paper cards. 
• Isolation of RNA from fresh blood samples followed by reverse transcription of the RNA 
into cDNA.  
Interrogation of each cDNA library for the quantity of specific mRNA transcripts that are 
associated with cyclic expression. 
 
V. What are the costs and payments associated with this study?  
 
Individuals willing to contribute blood samples for this study will receive no compensation for 
donating small blood samples. 
 
 




You may have some brief physical pain and bruising when we collect your blood. There is a small 
chance that you may get an infection, have excess bleeding, become dizzy, or faint from the 
blood draw.  
 
 
VII. Are there any benefits to participating in this study?  
There are no known direct benefits to you for participating in this study. Your 
participation will help us contribute knowledge to the field of forensic science. 
Specifically, we are attempting to strengthen the investigative capabilities of a 
forensic scientist to reconstruct the events surrounding a crime. This enhancement 
will lead to more effective prosecution of criminals and therefore enhanced public 
safety. 
 
VIII. How will you protect my privacy?  
 
We will protect your privacy in several ways:  
• We will store your signed consent form in a locked file, only Dr. Robert Allen will have 
access to this file.  
• We will not label your sample with your name or other identifying information (such as 
address, birth date, or Social Security number). Upon collection, samples will be given a 
10-digit identification code that will remain with the sample throughout the analysis 
process. The sample and data associated with that sample will only ever be referred to 
with that 10-digit code.  
• We will keep a record of each sample, the name of the person who donated the sample, 
the code associated with that sample, and the date and time of sample collection. This 
record will be kept in a locked file, unassociated with the samples or sample data that 
only Dr. Robert Allen will have access too.  
• Samples will be stored in a card-key access, secured storage room that only Dr. Robert 
Allen (principal investigator) and Dr. Jun Fu will have access too. However, the only 
identifiers on each sample Dr. Fu has access to will be the identification codes discussed 
above that identify the sex of the donor and the time a sample was collected and 
spotted onto a stain card of other solid substrate.  
• Samples that are not used will be destroyed upon completion of the study.  
The duration of the study will be no longer than 3 years and upon completion of the study, all 
biological samples will be disposed of in biological waste. The key connecting individual 
biological samples to donors will also be destroyed upon completion of the study by shredding 





IX. Can I change my mind after I decide to participate?  
 
Your participation in this research study is voluntary. You are free to refuse to participate in 
any procedure and to refuse to answer any question at any time, and are free to withdraw 
consent, and to withdraw from the research at any time during the study without penalty, 
including your relationship with OSU. Note that if you withdraw from the study as a semen 
donor, you will not be compensated.  
 
Any specimen(s) obtained for the purposes of this study will become the property of the 
School of Forensic Sciences, OSU CHS. Once you have provided the specimens, you will not 
have access to them. The specimen(s) and the key connecting individual biological samples 
with a donor will be destroyed following completion of the study using an appropriate 
means for destroying biological samples. The sample key will be destroyed via shredding 
with a secure shredder. 
If you wish to withdraw from the study, contact Robert W. Allen, PhD, at 918-561-1292. If you 
wish to withdraw from the study after the completion of the study, all information and data 
obtained from your biological sample(s) will remain as a part of the study even after the 
biological sample(s) are destroyed. 
If you have any questions about your rights as a research participant while in this study, please 
contact the Director of Institutional Review Board, Amber Hood, MS, at 918-561-1413. 
 
CONSENT TO PARTICIPATE 
 
Please read the information below, think about your choice and sign if you agree. 
 
I agree to donate the following sample type (please circle all applicable sample types) 
 
Venous Blood   Capillary Blood 
 
I have read and been given information about this research study and the risks involved have 
been explained to me. Any questions I may have had were answered to my satisfaction, and I 
have been told who to contact should additional questions arise. As a result, I give my informed 




Participant Signature                                                           Date 
Copy given to participant: ______Yes 
 
*Funding for this research is solicited from the National Institute of Justice Grant; Research and 





APPENDIX C: Volunteer Survey 
 
 
Circadian Rhythm Expression Study 
 
Sample Identifier #__________________                   Gender (circle one)  M       F 
 
Age (circle one)  18-24     25-30     31-35     36-40     41-45     46-50     51-55     56-60     61-70     71+ 
 
When time do you usually start your sleep cycle?    _____________ 
What time do you usually end your sleep cycle?      ______________ 
What is your average hours of sleep per night?       ______________ 
Has your normal sleep routine been interrupted in the last 4 days? yes____  no ____ 
Do you sleep in a dark or lighted room? ______________ 
Do you wake frequently (>5 times) during your sleep cycle? yes____  no ____ 
Have you used a sleeping aid (ie. cpap, medication) in the past week?   yes____  no ____ 
Do you have a consistent schedule (work, school)? yes____  no ____ 
What time is your typical breakfast _______lunch_______ and dinner _______?  
 
 







Specimen type________________  Specimen collection date___________ time___________ 
Collector initials______________      




APPENDIX D: Blood Sample Collection and Handling Instructions 
 
 
Thank you for your willingness to do this to yourself and/or others. 
 
As I am typically brain challenged I thought some directions might be helpful for those that do not have  
 
an identic memory.  I am researching circadian rhythm, in that different transcripts 
 
will exhibit different levels throughout the day. It is my hope those levels are reliable and  
repeat within a sensitive range. In this way, we will be able to predict time of a sample. 
 
Directions: I need a sample of blood every 4 hrs (I’m sorry)       Collection times need to be 4am,  
 
8am, 12pm, 4pm, 8pm, and 12am(midnight). I have provided sample cards for which to spot samples. 
Try not to touch the paper that you will be spotting as fingers contain RNase and will destroy your  
 
samples. This goes for spotting sampling and holding cards. The blood spot                      should be about  
 
the size of a nickel. Try to keep collection times as close to the designated time as possible.  
 
Note the date/time near the spot if possible. Do not use the defined circles because we need 6 samples. 
After collecting blood allow spot to air dry at room temperature. Do not place damp spotted card into 
plastic bag as this will cause increased degradation and possible contamination.  
I have included an alcohol swab and a spring-loaded lancet.                Clean your finger with the alcohol  
 
pad, like you know we do, uncap the lancet, just place the it upright and press down. You can dispose of 
the lancets in sharps or send them back to me for disposal. 
 
 
Thanks tons                                            and please call me anytime (even 4am) if you have any questions. 
 
  Dianne 
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